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Abstract
Rift Valley fever (RVF) is a vector-borne disease transmitted by different mosquito species, especially
Aedes and Culex genus, to animals and humans. In November 2018, RVF re-emerged in Mayotte
(France) after 11 years. Up to the end of October 2019, 126 outbreaks in animals and 143 human cases
were reported. RVF mortality was 0.01%, and the number of abortions reported in polymerase chain
reaction (PCR)-positive ruminants was fivefold greater than the previous 7 years. Milk loss production in
2019 compared to 2015–2018 was estimated to be 18%, corresponding to an economic loss of around
€191,000 in all of Mayotte. The tropical climate in Mayotte provides conditions for the presence of
mosquitoes during the whole year, and illegal introductions of animals represent a continuous risk of (re)
introduction of RVF. The probability of RVF virus (RVFV) persisting in Mayotte for 5 or more years was
estimated to be < 10% but could be much lower if vertical transmission in vectors does not occur.
Persistence of RVF by vertical transmission in Mayotte and Reunion appears to be of minor relevance
compared to other pathways of re-introduction (i.e. animal movement). However, there is a high
uncertainty since there is limited information about the vertical transmission of some of the major species
of vectors of RVFV in Mayotte and Reunion. The only identified pathways for the risk of spread of RVF
from Mayotte to other countries were by infected vectors transported in airplanes or by wind currents.
For the former, the risk of introduction of RVF to continental France was estimated to 4 9 106 epidemic
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per year (median value; 95% CI: 2 × 10–8; 0.0007), and 0.001 epidemic per year to Réunion (95% 
CI: 4 × 10–6; 0.16). For the latter pathway, mosquitoes dispersing on the wind from Mayotte between 
January and April 2019 could have reached the Comoros Islands, Madagascar, Mozambique and, 
possibly, Tanzania. However, these countries are already endemic for RVF, and an incursion of RVFV-
infected mosquitoes would have negligible impact. 
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Amendment:  An editorial amendment was carried out that does not materially affect the contents 
or outcome of this scientific output. In the abstract, a sentence was amended to: 'For the former, the 
risk of introduction of RVF to continental France was estimated to 4 × 10–6 epidemic per year (median 
value; 95% CI: 2 × 10–8; 0.0007), and 0.001 epidemic per year to Réunion (95% CI: 4 × 10–6; 0.16).' 
To avoid confusion, the original version of the statement has been removed from the EFSA Journal, 
but is available on request, as is a version showing all the changes made. 
Summary
Rift Valley fever (RVF) is a vector-borne disease transmitted by a broad spectrum of mosquito
species, especially the Aedes and Culex genera, to animals (domestic and wild ruminants and camels)
and humans. RVF is endemic in sub-Saharan Africa and in the Arabian Peninsula, with periodic
epidemics characterised by 5–15 years of inter-epizootic periods.
The European Commission requested EFSA to assess the probability of overwintering of RVF virus
(RVFV), the risk of RVF spreading from Mayotte (located in the Indian Ocean between Madagascar and
Southeast coast of Africa (Mozambique) and close to Comoros) to other areas including other French
departments in the Indian Ocean or to continental France as well as the impact of the disease on
animal health and farm production in Mayotte.
The assessment of the impact of RVF on animal health and farm production from the time of its
initial occurrence to date in Mayotte is based on the data and information obtained from different
sources: (i) the official websites of the related ministries, authorities and services, (ii) the available
databases, (iii) the farmer association in Mayotte, COOPADEM, iii) the French Veterinary Authorities,
(iv) the laboratory of CIRAD1 in Reunion, (v) experts and (vi) from the scientific publications.
Mayotte is a small French Department with a high density of population and can be considered as a
unique epidemiological unit in relation to RVF epidemiology. The climate in Mayotte is tropical with a
temperature remaining high (25.4°C average) all year round and small variations in daily and annual
temperatures ranging from 15°C in the night to 31°C in the day. Rainfall is present all year round with
high peaks from late November to March. This climate provides favourable conditions for the presence
of RVF competent vectors almost all year round. The last agricultural census in 2010 reported that
12,000 small ruminants are present in Mayotte while for the bovines, the most recent update of the
population in 2017 shows that around 20,000 bovines are present in Mayotte. The size of the herds is
small, with 4.8 and 5.8 animals per farm on average for bovines and small ruminants, respectively. The
farming system in both bovines and small ruminants is traditional, mainly based on tethered grazing,
with low levels of biosecurity. Most of the herds are mixed herds with cattle and small ruminants.
There is evidence of illegal introductions of animals seropositive for RVF from the Union of Comoros
into Mayotte.
RVF had not been officially reported in EU and neighbouring countries until November 2018, when
it (re) emerged in Mayotte, a region that had remained disease free since 2007. This recent epidemic
lasted 10 months (November 2018 to August 2019) counting 126 outbreaks in animals and 145 cases
in humans. The recorded RVF mortality was 0.01%, and the number of abortions reported in PCR-
positive ruminants was fivefold greater than years before. Milk loss in 2019 compared to 2015–2018 or
production was estimated to be 18%, corresponding to an economic loss of around 191,000 EUR in all
of Mayotte. Since the limited data available do not allow for a solid estimation of the impact of the RFV
infections on animal health and production in Mayotte, it is recommended to implement a more
structured system for the recording of disease occurrence and possible production losses, including
abortions and milk production, in order to understand the impact of RVF infection in Mayotte. A better
implementation of the animal identification and registration system and tracing of movements would
be of benefit for this objective.
The assessment of the probability of persistence of RVF in the department of Mayotte was mainly
based on two previously published studies that addressed this question (Cavalerie et al., 2015; Metras
et al., 2017) and their predictions were compared in light of the different assumptions made by the
models. Both studies considered Mayotte to comprise a single livestock population with no distinction
between cattle, sheep and goats in terms of RVFV transmission nor allowance for spatial location of
hosts (i.e. the island was treated as a homogeneously mixed population of hosts and vectors). Both
studies suggested that the probability of RVFV persisting in Mayotte is low. Indeed, without vertical
transmission in the vector or the import of infected animals, persistence is unlikely. In fact, according
to the first study, which considered vertical transmission in vectors, the possibility of persistence of
RVF infection in Mayotte was estimated at 9.5% and 2.1% for a persistence of 5 and 9 years,
respectively. Whereas, for the second study where vertical transmission in vectors was not considered,
once importation of RVFV-infected animals stopped, the probability of RVF persistence was 0.26%.
Since, in general, the role of vertical transmission in RVF vectors for the persistence of the disease
from one year to another or even between inter-epizootic episodes is still poorly understood, long-term
studies about the prevalence of viable RVFV in immature stages of mosquitoes are recommended.
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In relation to the risk of RVF spread from Mayotte to other countries, the only identified possible
pathways are infected vectors transported in airplanes or by wind currents. For the former, the target
countries considered in relation to the number of flights were continental France and Reunion. The risk
of introduction of RVF to continental France was 4 9 106 epidemic per year (median value; 95% CI:
2 9 108; 0.0007), and 0.001 epidemic per year to Reunion (95% CI: 4 9 106; 0.16). For spread by
wind currents, the HYSPLIT model was used and showed that mosquitoes dispersing on the wind from
Mayotte between January and April 2019 could have reached some neighbouring countries, such as
the Comoros Islands, Madagascar, Mozambique and, possibly, Tanzania. However, these countries are
already endemic for RVF, and an incursion of RVFV-infected mosquitoes would have negligible impact.
Considering the risk of spread of RVF from Mayotte, it is recommended to improve actions preventing
introduction of infected vectors from Mayotte to other uninfected areas, such as Metropolitan France
and Reunion. Particular attention should be given to air traffic connections from Mayotte to exposed
areas (Reunion, Comoros, Madagascar, Kenya/France, Tanzania/France) and strengthen the
surveillance in neighbouring countries. Existing disinsectisation procedures should be maintained and
possibly improved.
Rift Valley Fever in Mayotte
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
General introduction-background information
Rift Valley Fever (RVF) is a disease affecting primarily domestic ruminants (cattle, sheep, goats,
camels) and some wild ruminants, that is caused by a single stranded RNA virus of the genus
Bunyaviridae.
RVF is a vector borne disease, transmitted primarily through various species of vectors (primarily
hematophagous mosquitoes). Certain species of vectors (Aedes mosquitoes) may act as reservoirs of
the disease during inter-epidemic periods, thanks to their potential for transovarian (vertical)
transmission of the virus to their eggs. As a result, new generations of RVF infected mosquitoes may
hatch from infected eggs, especially in periods of favourable conditions (e.g. high rainfalls).
Ruminants are infected primarily by vector bites. Clinical signs range from sudden deaths and
abortions to mild, non-specific symptoms, depending on the virulence of the strain and the species,
breed and age of the affected animals. Mortality may reach 70–100% in lambs and kids and 20–70%
in sheep and calves. Abortion rates may reach 85–100% within the affected herds. RVF in camels can
cause abortions and neonatal deaths. Infected wild ruminants usually do not demonstrate any clinical
signs.
Humans can become infected by RVF, through the bites of vectors, by contact with infected animals
and animal materials (blood, discharges, abortion materials etc.) or by consumption of untreated
animal products (fresh meat and/or raw milk). No human-to-human transmission has been recorded to
date. About 50% of infected humans have no clinical signs while the rest may demonstrate flu-like
symptoms. A small percentage, may develop severe clinical forms, involving haemorrhagic fever with
hepatic disease, meningoencephalitis or ocular complications. The total case fatality rate varies
between different epidemics (overall less than 1% in those documented).
To date no RVF outbreaks in humans or animals have been reported in Europe or countries sharing
land borders with the continental areas of the EU. The closest RVF evidence available is limited to
serological findings from retrospective studies carried out in Turkey, using blood samples collected
from camels, gazelles and buffaloes from 2000 to 2006.
Currently the disease is endemic in large areas of Southern and Eastern Africa, where outbreaks of
RVF occur periodically (e.g. every few years), in seasons when weather conditions favour competent
vectors. In recent decades large RVF epidemics have occurred in Egypt (1977–1978, 1993, 2003),
Mauritania (2010, 2012, 2015), Madagascar (2007–2009), Comoros (2007) and elsewhere in the
African continent (Kenya, Somalia, South Africa, Sudan, Senegal etc.). Egypt currently marks the
northernmost limit of RVF spread. The disease moved outside the African continent for the first time in
2000, into the Arab peninsula (Saudi Arabia and Yemen).
On 5 April 2017, EFSA, following a request from the Commission, adopted a scientific opinion on 36
vector-borne diseases, including RVF. The opinion, based on a semi quantitative risk assessment,
concluded that the risk of introduction of RVF in the EU was estimated to be very low.
In Mayotte, a French department located in the Indian Ocean, close to the Union of the Comoros
(Grande Comore, Moheli and Anjouan) islands and Madagascar, human cases of RVF were detected for
the first time in 2007. Retrospective serological studies demonstrated the presence of RVF in livestock
since 2004 (serological evidence). Until recently the disease appeared to be in remission with no new
human cases detected since 2011. However, in 2018, RVF re-emerged in Mayotte and between 22nd
November 2018 and 14th March 2019, more than 101 human cases and more than 60 outbreaks in
ruminants have been reported.
In response to the RVF resurgence, the competent authorities of Mayotte are implementing
surveillance and biosecurity measures, coupled with vector control/protection measures, aiming to limit
the overall disease spread and prevent animal-to-human transmission. In addition, movements of
ruminants and raw meat and milk thereof, originating from Mayotte, have been prohibited.
The Commission is empowered to adopt delegated acts supplementing the rules laid down in Part
III of Regulation (EU) 2016/429 on transmissible animal diseases (Animal Health Law) on disease
control measures for listed diseases as referred to in point (a), (b) and (c) of its Article 9 (category A,
B and C diseases). Therefore, a draft Commission Delegated Regulation laying down rules for the
prevention and control of certain diseases has been developed and the draft is in consultation.
Rift Valley Fever in Mayotte
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The rules laid down in the abovementioned draft Commission Delegated Regulation are largely replacing
the rules currently in force concerning the disease control measures in the event of animal diseases with
serious effects on the livestock as they have proven to be effective in preventing the spread of those
diseases within the Union. Consequently, animal disease control measures laid down in existing Directive
will be, if not already done so by the Animal Health Law, replaced by the rules provided in that Delegated
Regulation. This is also the case of Directive 92/119/EEC which currently provides for measures to apply in
the event of occurrence of certain diseases. This includes Rift Valley Fever, which is in accordance with
Commission Implementing Regulation (EU) 2019/1882, categorised as Category A disease.
In this regard, the existing rules of Directive 92/119/EEC will cease to apply for Rift Valley Fever as
from the date of application of the Animal Health Law and its complementing legislation, i.e. from 21
April 2021. The proposed measures for the prevention and control of RVF should be assessed in order
to ensure that they are updated based on the latest scientific knowledge in this new set of legislation.
Terms of Reference
1 RISK OF ENTRY OF RVF INTO THE CONTINENTAL PARTS OF THE EU
1.1 Provide an update of the global epidemiological situation in relation to RVF with
emphasis on areas posing a higher risk for the EU.
1.2 Provide an updated assessment of the overall risk of introduction of RVF (combined
rate of entry, vector transmission and establishment), separately for each one of the EU
regions potentially at risk, as specified in the 2017 EFSA scientific opinion on Vector-
borne diseases (VBD).
1.3 Provide a separate risk assessment of the risk of introduction of RVF for specific
Member States that may be at particular risk.
2 IMPACT OF RVF IN THE DEPARTMENT OF MAYOTTE AND RELEVANT CONTROL
MEASURES
2.1 Assess the probability of overwintering of RVF in the department of Mayotte
as well as the risk of RVF spreading from Mayotte to other areas including
other French departments in the Indian Ocean or Metropolitan France.
2.2 Assess the impact of the disease (as defined in the ‘VBD opinion’), with
emphasis on animal health and farm production in Mayotte from the time of
its initial occurrence to date.
2.3 Assess the possible short- and long-term effectiveness, of different control measures, in
eliminating or reducing the disease impact in Mayotte (as per TOR 2.2 above), namely:
2.3.1 Stamping out of RVF outbreaks;
2.3.2 Establishment of a protection and a surveillance zone around RVF outbreaks;
2.3.3 Biosecurity measures, as the ones currently in place in Mayotte, coupled with
personal sanitary protection measures related to human–animal contact, including
measures to prevent consumption of potentially infected meat and milk;
2.3.4 Vector control and protection measures;
2.3.5 Vaccination of livestock;
2.4 Assess the possible effectiveness of different surveillance strategies in animals that may
be used for RVF detection and possible prediction of RVF recurrence in Mayotte in the
future, in view of the diagnostic methods currently available.
3 SURVEILLANCE AND CONTROL MEASURES FOR RVF [IN CASE OF OCCURRENCE OR HIGH
RISK OF RVF INCURSION IN EUROPE]
3.1 In case of high risk of RVF introduction in Europe, assess and describe the surveillance
measures necessary to ensure early detection of the disease.
3.2 In case of RVF occurrence in Europe, assess the effectiveness of the main available
disease prevention and control measures for RVF, including the relevant measures
provided for in the draft Commission Delegated Regulation on rules for the prevention
and control of certain listed diseases under Part III of Regulation (EU) 2016/429 on
transmissible animal diseases (Animal Heath Law9), namely their potential to:
– limit the geographical spread of the disease
– reduce the number of outbreaks
Rift Valley Fever in Mayotte
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– reduce the overall impact of the disease being present in an area for prolonged
periods (e.g. in case overwintering is possible)
In particular, assess the feasibility, availability and effectiveness of:
3.2.1 the general measures set out in the enacting terms of Part I and II of draft
Commission Delegated Regulation
3.2.2 the disease-specific measures set out in Annexes I to X to draft Commission
Delegated Regulation
3.2.3 vaccination of listed species, including assessment of possible:
– risk mitigating measures necessary to be put in place for animals and products of
animal origin thereof, following vaccination
– surveillance performed after vaccination.
1.2. Interpretation of the Terms of Reference (if appropriate)
It was agreed with the European Commission to address the ToRs in three scientific opinions to be
delivered according to the following deadlines:
• January 2020 for the ToRs 1.1, 1.2 and 1.3
• March 2020 for ToRs 2.1 and 2.2
• September 2020 for ToRs 2.3, 2.4 and 3.
The present opinion deals with ToRs 2.1 and 2.2, i.e. the RVF situation in Mayotte, in particular the
probability of overwintering of RVF, the risk of RVF spreading from Mayotte to other areas such as
other French departments in the Indian Ocean or Metropolitan France, and the assessment of the
impact of the disease, with emphasis on animal health and farm production from the time of its initial
occurrence to date.
Probability of overwintering of RVF in the department of Mayotte
In Mayotte, the tropical climate allows the presence and activity of insect vectors throughout the
year, with some difference in mosquito abundance linked to the rainfall in the two main seasons, rainy
season or dry season. Given the climate in Mayotte, therefore, the term ‘overwintering’ must be not
interpreted as in temperate areas, where the winter temperature hampers the vector life cycle, but
should be interpreted as the possible persistence of RVF virus throughout the year, during the inter-
epizootic periods. These aspects are addressed in Section 3.2.
Risk of RVF spreading from Mayotte to other areas including other French departments in
the Indian Ocean or Metropolitan France.
Concerning the risk of RVF spread from Mayotte to other areas, including other French departments
in the Indian Ocean or Metropolitan France, the only French department in that area is Reunion, for
where there is no evidence that the livestock has ever been affected by RVFV. Other countries
neighbouring Mayotte are Madagascar, Comoros, Kenya, Tanzania, Mozambique, Mauritius, which are
not French departments. Apart from Mauritius, all these countries were already affected by RVFV
before the emergence of RVF in Mayotte (EFSA AHAW Panel, 2020). The target countries and the
related pathways to be considered for the assessment of possible spread from Mayotte are discussed
in Section 3.3.
Impact of the disease (as defined in the ‘VBD opinion’), with emphasis on animal health
and farm production in Mayotte from the time of its initial occurrence to date:
In the VBD opinion (EFSA AHAW Panel, 2017), the impact of the disease being present in an area
was intended as the combination of the impact on animal health, the production losses in affected
farms, and on public health. In this opinion, the impact on animal health due to RVF epidemics in
Mayotte is assessed considering the morbidity and mortality registered in outbreaks of RVF in the
island, the number of abortions observed and attributable to RVF infection and the occurrence of cases
of flu-like syndromes in cattle. For the impact on animal production, the effect on milk production was
assessed on the basis of the milk drop observed in 2019 in one study of a bovine dairy farm. The ToRs
do not request an assessment on public health impact; thus, this latter aspect is not included in the
opinion. The impact of RVF in Mayotte is assessed in Section 3.1.
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2. Data and methodologies
2.1. Data
2.1.1. Epidemiological data
Historical and current data and information on the epidemiology of RVF in Mayotte, in relation to
the outbreaks and cases in animals and humans, were obtained from World Organisation of Animal
Health (OIE), Animal Disease Notification System (ADNS), French Veterinary Authorities and from the
World Health Organisation (WHO)2 and from Agence Regionale de Sante (ARS) Mayotte (Regional
Health Agency of Mayotte)3 for human cases. In addition, information from publications was used.
Data and information on the RVF laboratory analyses and the results were provided by the French
Agricultural Research Centre for International Development (CIRAD, Centre de Cooperation
Internationale en Recherche Agronomique pour le Developpement), which is the French RVF national
reference laboratory (NRL) with laboratory facilities located in Reunion.
An animal health surveillance system, named SESAM, has been in place in Mayotte since 2009. It is
jointly managed by CIRAD, the French veterinary services DAAF 976 and COOPADEM, a farmer’s
cooperative. SESAM includes data on RVF seroprevalence, occurrence of flu-like syndromes and
abortions in farmed ruminants. Data from SESAM were obtained from COOPADEM and CIRAD. Data on
seroprevalence of RVF were also gathered from several studies based on samples collected from 2004
to 2019 as follows, from 2004 to 2015 (Cetre-Sossah et al., 2012a,b; Metras et al., 2016) and from
2016 to 2019 (Direction de l’Alimentation, de l’Agriculture et de la Fore^t (DAAF), CIRAD, COOPADEM).
Concerning data on abortions, the number of cases and the results of laboratory investigations
were obtained both from SESAM and from the French Departmental laboratory in Mayotte, which
routinely tests aborted fetuses in the framework of the brucellosis national surveillance plan.
Since there are no milk processing plants in Mayotte, no data on milk production that would allow
the identification of any variation in milk production are available. COOPADEM provided data on milk
production losses from a farm affected by RVF that had historical records of milk production.
2.1.2. Data on climate, geographical and demographical characteristic
Data on climate, on temperature and on precipitation in Mayotte were obtained from the website of
METEO FRANCE.4 Demographic data were obtained from Institut national de la statistique et des
etudes economiques (INSEE), France.
2.1.3. Data on animal populations
Data on animal populations and farm management that have been used for this Opinion were
derived from the websites of the Statistic and Prospective Service of the French Ministry of Agriculture
and Food (Le Service de la statistique et de la prospective, Ministere de l’ Agriculture et de l’
Alimentation5) and from the Direction of Food, Agriculture and Forestry (Direction de l’ Agriculture de l’
Alimentation et la Foret, DAAF) of Mayotte.6 They include the data from results of the last agricultural
census carried out in 20107 in Mayotte and other statistical publications and studies carried out by the
above-mentioned services.
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2 WHO, Disease Outbreaks News: https://www.who.int/csr/don/13-may-2019-rift-valley-fever-mayotte-france/en/
3 ARS Le Reunion hosted the archives of the press releases in relation to the diseases: les archives des communiques de presse
diffuses par l’ARS Ocean Indien en 2019: https://www.lareunion.ars.sante.fr/communiques-de-presse-de-lars-ocean-indien-2019
4 Meteo France : http://www.meteofrance.yt/climat/description-du-climat; and http://www.meteofrance.yt/climat/suivi-climatique-
recent/an-2019
5 Resultats du recensement agricole 2010, Mayotte : Synthese illustree du recensement agricole 2010 - Elevage - juin 2011
(PDF: 1.4 Mo) - 13/9/2011; http://agreste.agriculture.gouv.fr/IMG/pdf_D97611A05.pdf
6 DAAF: http://daaf.mayotte.agriculture.gouv.fr/Statistiques.
7 Resultats du recensement agricole 2010, Mayotte: L’essentiel du recensement agricole 2010; http://daaf.mayotte.agriculture.gouv.
fr/IMG/pdf/RA_2010_Mayotte_Essentiel_cle0d6212.pdf
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2.1.4. Data on trade and travel activities
Data on outbound flights from Mayotte for 2019 were provided by the Operations and Maintenance
Infrastructure of the Mayotte Airport Dzaoudzi – Pamandzi8 (Operations et Maintenance Infrastructures
de l’ Aeroport de Mayotte) at monthly level.9
Data from 2015 to 2019 related to the trade movement from Mayotte to metropolitan France, other
French departments in the Indian Ocean (Department of Reunion), the Union of Comoros, Madagascar
and Mauritius were collected from TRACES, EUROSTAT and UN COMtrade.10
2.1.5. Data on vectors
The potential vector species of RVFV in Mayotte and Reunion were identified through a literature
review. In particular from the risk assessment of AFSSA (2008), the review of Linthicum et al. (2016)
on the RVFV species in endemic countries; the role of vectors in the area of the Indian Ocean
reviewed by Balenghien et al. (2013) and the only publication on the survey of mosquitoes from
Mayotte by Le Goff et al. (2014). In this opinion, field and/or laboratory evidence of RVFV were listed
for all the mosquito species reported in Reunion and Mayotte. Abundance and distribution in the
territories of concern were also extracted from literature when available to determine main vector
species based on vector competence, high abundance and wide distribution in both islands.
Information of main vector species was used to assess the possible spread of RVFV to other territories
(i.e. Reunion and mainland France). We also assessed the main vector species present in Reunion to
compare similarity on vector species to those found in Mayotte. Data on the presence/absence of
Aedes aegypti, Aedes albopictus and Culex quinquefasciatus were taken from the survey conducted by
CIRAD and are available at https://www.mosquito-maps-oi.fr/ (A. Tran, CIRAD, UMR TETIS).
2.2. Methodologies
2.2.1. Methodology for assessing the impact of RVF in Mayotte (TOR 2.2)
The impact of RVF in Mayotte was estimated through the descriptive epidemiological analysis of the
RVF epidemics focusing on seroprevalence, mortality, morbidity, abortions and production losses.
For the latter, a study on the milk production implemented on one single educational bovine dairy
farm, with 10 adult lactating cows on average, was considered. During this study, the amount of milk
produced by dairy cows on the farm was monitored from 2015 to 2019. In January 2019, the farm
was affected by RVF (laboratory confirmed on 23/1/2019) with abortions. The milk loss was assessed
by comparing the production in 2019 with the production of the previous years 2015–2018, as a
reference period. As in a quality control process, the milk production anomaly was assessed per each
week in 2019 against the reference period. The milk production rate anomaly (MPA) is defined as the
relative difference between the actual production of milk and the 95% CI bounds of the long-term milk
production rate (considered as a reference). Specifically, MPA(t) = 0 for p2.5 ≤ MP(t) ≤ p97.5, MPA(t) =
100 9 [MP(t)/p2.5 – 1] for MP(t) < p2.5 and MPA(t) = 100 9 [MP(t)/p97.5 – 1] for MP(t) > p97.5,
where MP(t) is the milk production at the date t and p2.5 and p97.5 are the 2.5 and 97.5 percentiles
of the reference. In other words, the reference or long-term production provides the ranges of
production that would be expected; the anomaly is the difference between what is happening and
what one would expect. MPA provides the deviation from the ‘normal’. A positive anomaly means that
the production is higher than normal; a negative anomaly indicates that the production is lower than
normal. Likewise, the milk deficit is calculated as the cumulation of the difference between actual
quantity of milk produced at the date t in 2019 and the 2.5 and 97.5 percentiles of the milk produced
during the reference period.
For the estimation of the total economic losses in Mayotte in 2019 deriving from a drop in bovine
milk production due to RVF infection, the following formula was used:
CostRVF ¼ nm t p c; (1)
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8 Mayotte airport: http://www.aeroport-mayotte.com/
9 Airport of Mayotte: http://www.aeroport-mayotte.com/sia/M.pdf)
10 UN Comtrade is a repository of official international trade statistics and relevant analytical tables. It provides free access to
detailed global trade data through an API.
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where:
• n: Number of dairy animals affected by RVF in Mayotte
• t: Period (year)
• m: Amount (litres) of milk produced in 1 year/per cow
• p: Proportion of milk reduction
• c: Cost for 1 litre of milk (euros)
The number of dairy animals affected by RVF (n) is an unknown variable and the data reported in
the ADNS for RVF outbreaks occurring in the whole island of Mayotte were considered for its
estimation, considering both the number of animals affected by RVF disease and the total number of
animals present in the outbreaks, to provide two possible ranges of estimates.
The period of the year (t) considered was 8 months (8/12 = 0.67), from December 2018 to July
2019, during which RVF outbreaks were recorded in Mayotte.
The average milk produced per cow (cross-breeding animal) per year (m) was considered equal to
2400 litres of milk (DAAF976, 2018).
For the proportion of milk reduction (p), the results of the analysis of milk production records in the
above-mentioned study farm were used.
The cost of 1 litre of milk (c) sold in Mayotte was on average equal to 4 euros/litre (CIRAD, 2013).
Given the long period of observations, the results of this study are very useful for estimating the
indirect effects RVF infection in milk production due to abortions and other perturbations of the
reproductive sphere of cows. However, due to the extremely limited number of animals under study
(this may be the main source of uncertainty), a careful interpretation of the results is needed,
especially when the reduction in milk production in the whole bovine population of the island must be
inferred.
In addition, further information is provided on the factors that may be linked with the impact of
RVF such as climatic, geographical and demographic factors in Mayotte.
2.2.2. Methodology for assessing the probability of RVFV overwintering (TOR
2.1)
The RVF epidemiological cycle of Mayotte consists of animal hosts and mosquito vectors both
present all year round. Because of weather conditions in Mayotte, there is no break in both mosquito
abundance and mosquito activity, although there are seasonal trends. The transmission of RVF is likely
to occur all year round in Mayotte. Therefore, the overwintering question in Mayotte system is posed
in terms of how long the RVF infection can persist in such a context in the absence of any
introduction.
The probability of RVFV persistence (overwintering, see Section 1.2) in Mayotte was assessed in
two previously published modelling studies (Cavalerie et al., 2015; Metras et al., 2017). The results of
these studies were used as the basis for the assessment, considering the assumptions underlying the
two models, as well as their results and predictions.
For assessing the role of vertical transmission for the persistence of RVFV from one year to another,
evidences were retrieved from literature, in particular from the complete review of the role of vertical
transmission of RVFV by mosquito vectors conducted by Lumley et al. (2017).
Sources of uncertainty related to the vector’s role in the maintenance of the RVFV in Mayotte and
Reunion were a lack of data and possible overestimation of current evidences related to vertical
transmission.
2.2.3. Methodology for assessing the risk of spread from Mayotte to
neighbouring countries in the Indian Ocean or to continental France (TOR
2.1)
Concerning the risk of RVF spread from Mayotte to other areas including other French departments
in the Indian Ocean or Metropolitan France, the possible pathways of spread of RVF from Mayotte
were discussed and the relevant ones selected based on literature and expert knowledge. These are
discussed in Sections 3.3.2–3.3.3.
Two pathways were selected for a more in-depth risk assessment: windborne spread of infected
vectors and movement of vectors carried in airplanes. The HYSPLIT model11 (REF) has been used to
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assess the windborne movement of infected vectors, while MINTRISK model (details are provided in
first opinion on RVF published under this mandate, EFSA AHAW Panel, 2020) is used to assess the
possible spread by movement of vectors by flights (Section 3.3.4).
For the latter pathway, the target countries to be considered are only Metropolitan France and
Reunion, which is the only French department in that area that was never affected by RVF. For the
former pathway of spread, windborne spread of infected vectors, the countries considered are the
ones neighbouring Mayotte, i.e. Madagascar, Comoros, Kenya, Tanzania, Mozambique, which are all
countries endemic for RVF and were affected earlier than Mayotte (EFSA AHAW Panel, 2020). Mauritius
is quite far away from Mayotte island and there are no direct trade, airplane or other connections with
Mayotte. For this reason, Mauritius was excluded from the assessment.
MINTRISK model
The MINTRISK model is a tool to assess the level of introduction, transmission and impact of
vector-borne diseases. MINTRISK stands for Method to INTegrate all relevant RISK aspects; it is a tool
developed in Excel and Visual Basic. A web-based version with a central database and using C-sharp
for underlying calculations has been created for practical use and access.12 This tool allows for a
systematic, semi-quantitative risk assessment, which can be used for risk evaluation, risk comparison
and risk ranking of possible vector-borne diseases of livestock.
The MINTRISK approach to assess the overall risk of pathogen/disease introduction into the EU
involves four steps: worldwide occurrence, risk of entry, level of transmission and probability of
establishment.
The probability of each step of the risk pathway was calculated. First, the occurrence, rates of entry
(number of entries/year), level of transmission (R0, basic reproduction number) and probability of
establishment were calculated separately, and then, these three values were combined into an overall
rate of introduction (number of epidemics/year). The calculation of the probability of each step was
based on the answers to a set of questions to be addressed. Possible answers were qualitative
categories associated with a level of the uncertainty (low, moderate, high13). A Monte Carlo simulation
was used to determine the overall uncertainty in the probability for each step of the pathway and for
the overall probability. For most of the questions, the answer categories were given on a logarithmic
scale and the outcomes were always expressed on a logarithmic scale.
Wind-borne dispersal of mosquitoes
To explore the potential for RVFV-infected mosquitoes to be transported by wind to or from
Mayotte, we used the Hybrid Single-Particle Lagrangian Integrated Trajectory model (HYSPLIT) (Stein
et al., 2015; Rolph et al., 2017). HYSPLIT is a complete system for computing simple air parcel
trajectories (as used here), as well as complex transport, dispersion, chemical transformation and
deposition simulations, and is freely available online (https://ready.arl.noaa.gov/HYSPLIT.php).
HYSPLIT has been used previously to investigate long-distance dispersal of other vector species (see,
e.g. Durr et al., 2017; Huestis et al., 2019).
When assessing incursions of RVFV-infected mosquitoes to Mayotte backward trajectories of 48 h
duration were computed for the 28 days prior to 1 January 2008 (i.e. around when the previous
epidemic was predicted to have started) or 1 December 2018 (i.e. around when the first cases were
reported in the recent epidemic). Air parcels (which could contain mosquitoes) were released every 6 h
over the period of interest at 100 m above ground level from a location near the centre of Mayotte
(12.83°S, 45.16°E). Their trajectories were then calculated backwards in time for 48 h to indicate
where they had originated. The 100 m was chosen as roughly the midpoint of the atmospheric
boundary layer. However, exploratory analysis suggested that the conclusions of the modelling were
not particularly sensitive to the choice of release height.
When assessing dispersal of RVFV-infected mosquitoes from Mayotte, forward trajectories of 48 h
duration were computed from January to April 2019 (i.e. when the majority of outbreaks were
reported). Air parcels were released every 6 h over each month at 100 m above ground level from the
same location near the centre of Mayotte. Their trajectories were then simulated for 48 h to indicate
Rift Valley Fever in Mayotte
12 https://www.wecr.wur.nl/mintrisk/ModelMgt.aspx
13 Three uncertainty levels can be selected to describe the certainty when answering the questions in the MINTRISK model. The
model will sample a value from triangular distributions with different ranges around the answer category according to the
chosen uncertainty level for a ‘moderate’ answer category. The ranges around the answer category are +/0.1 for low, +/0.3
for moderate and +/0.5 for high uncertainty (EFSA AHAW Panel, 2017).
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where they had moved to. Meteorological data from the Global Data Assimilation System (GDAS; at 1°
resolution) were used in the simulations.
It is important to note this analysis does not consider factors such as mosquito flight behaviour or
survival during transport (e.g. because temperatures become too low). It also does not consider the
number of mosquitoes dispersing or the proportion of these which are infected with RVFV. Accordingly,
it does not provide a detailed risk assessment for the introduction of RVFV via wind-borne dispersal on
infected mosquitoes. Rather the HYSPLIT modelling gives an indication of locations which could either
be a source of RVFV-infected mosquitoes for Mayotte or be at risk of introduction of RVFV via long-
distance dispersal of mosquitoes from Mayotte. Results are presented in Section 3.3.5.
3. Assessment
3.1. Assessment of the impact of RVF in Mayotte (TOR 2.2)
This section is dealing with the assessment of the RVF impact on animal health and production in
Mayotte. Besides the epidemiological analysis, some background information is provided on livestock
sector, geography, climate and demography in Mayotte that may influence RVF impact.
3.1.1. Geographical and climate characteristics of Mayotte
Mayotte is located in the southern hemisphere, between the equator and the Tropic of Capricorn, at the
entrance to the Mozambique Channel, halfway between Madagascar and southeast coast of Africa
(Mozambique) and close to Comoros. Mayotte is approximately 100 km from Comoros, 400 km from
Mozambique, 600 km from Tanzania, 1,300 km from Reunion, 8,000 km frommainland France (Figure 1).
The total surface of Mayotte is estimated at 376 square km. It consists of two inhabited islands:
the main island, Grande-Terre (or Maore) of 363 square km and a smaller island, Petite-Terre (or
Pamanzi) of 11 square km and 30 uninhabited islets around these two (Ministere des Outre-mer).
Figure 1: Land use and geographical position of Mayotte in the Indian Ocean
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Information about climatic conditions14 were retrieved from METEO France￼. The climate in
Mayotte is tropical, hot, humid, maritime characterised by small variations in daily and annual
temperatures and significant rainfall (more than 1,500 mm per year). The average temperature in
Mayotte is 25.4°C.
The two main wind systems affecting the island are the Monsoon winds that are hot and humid
with direction from north to northwest; and the trade winds generated by the anticyclones of
Mascareignes,15 that are cool and dry, with direction from southeast (METEO FRANCE10). As a
consequence of these two winds in Mayotte, there are two main seasons during the year, separated by
two shorter (METEO France):
i) The hot and rainy season, from December to March; the Australian summer or ‘kashkasini’.
The temperature regularly ranges around 32°C during the day and 21°C at night while the
humidity ranges from 85% to 95% (METEO FRANCE).
ii) the cold and dry season, from June to September; Australian winter or ‘kussini’ (METEO
France). The minimum temperature can drop to 10°C during the night on the island and it is
not uncommon to see several months without rain (METEO FRANCE).
One short season is ‘Matulahi’, which lasts from April to May, dominated by southeast winds and
the other one, the ‘M’gnombeni’ lasts from October to November with northeast winds.
The maximum and minimum temperatures per month, the monthly mean temperature and
precipitation variations during the period of the recent outbreaks (August 2018–August 2019) are
presented in Figure 2, based on the data obtained from METEO FRANCE; the temperature variation is
limited, and the temperature remains above 15°C all year round.
3.1.2. Human demographic characteristics of Mayotte
The population of Mayotte in September 2017 was 256,518 people (INSEE, 2019)17 and remains
the French Department with the greatest demographic growth. Mayotte can be considered as a very
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Figure 2: The mean, minimum and maximum temperatures and precipitation levels in Mayotte per
month, from July 2018 until September 2019. Source of information: METEO France16
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14 Meteo France: Mayotte Description of climate, http://www.meteofrance.yt/climat/description-du-climat
15 Mascarene Islands: Mauritius, Reunion, and Rodrigues.
16 Meteo France, Climate, Suivi Climatique: http://www.meteofrance.re/climat/suivi-climatique-recent/an-2019
17 L’Institut national de la statistique et des etudes economiques (INSEE): https://www.insee.fr/fr/statistiques/3284395
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densely populated island with 682 habitants per square km given that it is only overtaken by Paris and
five other Departments of I^le-de-France.18 Half of the population of Mayotte does not hold French
nationality, but one-third of foreigners were born in Mayotte. In the municipalities of north-east
Mayotte around Mamoudzou, many inhabitants arrived from the Comoros Islands (INSEE, 2019). The
population of Mayotte is young: half of the inhabitants are under 18 years of age. Mayotte experiences
illegal immigration, mainly from the Comoros, and thus, a regional cooperation has been developed
with the Union of Comoros to better manage the migratory flows. The dominant religion in Mayotte is
Islam, with 95% of the population being Sunni Muslims.
3.1.3. Livestock in Mayotte
The last agricultural census of the total animal population in Mayotte was carried out in 2010.5,19
During the census, all the animals that were present were registered. According to the results, in
Mayotte, there were 3,581 bovine herds with a total amount of 17,154 bovines and 4.8 was the
average number of heads per herd. The size of the herds was small, since most (60%) of the herds
had less than five animals. 36% of the herds had one or two animals, 24% had 3–5 animals, 9% had
6–10 animals and 31% more than 10 animals. Dairy herds accounted for 22% of the bovine herds.
The management of the herds remains traditional and depends on the size of the herd.
Approximately 72% of the bovine herds were still raised tethered outside the premises, rather than on
pastures belonging to their owners. Only 23% of the herds were known to remain inside the premises.
In relation to small ruminants, there were 2,189 sheep and goat herds, with a total amount of
12,619 animals. 93% of these herds were goat herds with a total of more than 11,500 animals. The
size of the sheep population was one-tenth of the goat population, with barely 1,100 animals in total.
The size of sheep and goat herds was small, with an average of 5.8 heads per herd. Herds with
between 5 and 10 animals constituted 39% of the total number of herds and 45% of the total number
of small ruminants. The management system was traditional; food supplements were provided to 21%
of the animals. Approximately 51% of the herds were led to areas of free grazing whereas 46%
remain in the premises.
More detailed data on animal population in Mayotte, based on the last census of 2010, are
presented in Appendix A and an overview of the density of animals and herds in different
municipalities (‘communes’) in Mayotte, based on the proportions on the total number of herds and
animals per species., is illustrated in Figures 3 and 4.
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18 Ministere des Outre-Mer http://www.outre-mer.gouv.fr/mayotte-1.
19 Resultats du recensement agricole 2010, Mayotte: L’essentiel du recensement agricole 2010 (http://daaf.mayotte.agriculture.gouv.
fr/IMG/pdf/RA_2010_Mayotte_Essentiel_cle0d6212.pdf).
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Figure 3: Proportional distribution of bovine herds (on the left) and of bovine animals (on the right)
per commune (LAU 2) in Mayotte. The percentages were calculated based on the results of
the last Agricultural Census having taken place in Mayotte in 201019
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There are some more recent updates of bovine population data, in 2016 and 2017, that can be
found in the website of DAAF20 and according to which the total number of bovines in Mayotte was
20,232 and 20,478, respectively.
The population of small ruminants has not been updated recently and is based on the data from
the last census performed in 2010 (French Veterinary Authorities, emails November 2019, January
2020). No camels are present in Mayotte.
According to the information provided by the French Veterinary Authorities, the registration and
identification system in Mayotte is not fully in compliance with the EU legislation; there is no detailed
information at the farm level, the farms are not geolocated and the data on animal numbers are
incomplete and not regularly updated.
No wild ruminant species are present in Mayotte.
Figure 4: Proportional distribution of ovine and caprine herds (on the left) and of ovine and caprine
animals (on the right) per each Commune (LAU 2) in Mayotte. The percentages were
calculated based on the results of the last Agricultural Census having taken place in
Mayotte in 2010
Table 1: Total number of animals per species and per year, in Mayotte (Source: DAAF Statistiques)
Species 2003 2010 2016 2017
Bovine 17,235 17,152 20,232 20,478
Caprine 22,811 11,542 na na
Ovine 1,499 1,077 na na
Na: not available.
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20 DAAF Direction de l’Alimentation, de l’Agriculture et de la Fore^t de Mayotte: http://daaf.mayotte.agriculture.gouv.fr/Memento
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Production
Milk production is only cow milk; 22% of the bovine herds in Mayotte are for milk production. Given
the absence of milk processing plants, it is very difficult to come up with precise numbers on production.
The estimated dairy cattle population is approximately 2,200. The recent introduction of genetics from
the Montbeliarde breed has raised the milk production per cow from 1,000 to 1,500 litres per year to
2,500 litres per year. Milk is sold around €4 per litre5. The milk consumption per resident is estimated
between 35 and 50 litres of milk per year, of which 75% is imported milk (UHT or in powder).21
For the meat production, given the absence of slaughterhouses, it is also very difficult to come up with
precise numbers. Mostly local zebus are used for meat production, in Mayotte, there are approximately
20,000 cattle in 3,600 herds, of which 4,000 are slaughtered per year with an average carcass weight of
120 kg and an average of 490,000 kg of meat per year. The meat is sold from €10 to €14 per kg.11
According to the 2010 census, the meat production from approximately 12,000 small ruminants
corresponds to 35,000 kg of caprine and 5,000 kg of ovine meat.
3.1.4. Administration and organisation of livestock sector and veterinary
diagnostics in Mayotte
Mayotte and Reunion are the two Overseas French Departments (Department d’outre mer; DOM) in
the Indian Ocean.22 Mayotte became officially the 101st Department of France on 31 March 2011
(Ministere de l’Interieur). In 2014, Mayotte also changed status at European level, becoming an
outermost region, and has since become part of the European Union. Mayotte is classified at NUTS 2
and three administrative levels according to the European Legislation and is divided into 17
Municipalities (Communes) (LAU 2 level) (http://www.outre-mer.gouv.fr/mayotte-1).
The French Government exercises the authority in all Overseas Departments through the Ministry of
Overseas (Ministere des Outre-Mer). In relation to the field of agriculture, the Departmental
Directorate for Food, Agriculture and Forestry (Direction departementale de l’alimentation, de
l’agriculture et de la fore^t, DAAF23) is a decentralised service of the state, with inter-ministerial
competence, placed under the authority of the Prefect of Mayotte and reporting to the French Minister
of Agriculture. The Veterinary Authority for animal health of Mayotte is based in the Directorate for
Food, Agriculture and Forestry: Unit of Animal Health and Welfare (Unite Sante et protection animales)
under the Food Service (Service de l’ Alimentation, SA) (DAAF Organisation chart24).
In Mayotte, there is a public institution named ‘Chambre de l’Agriculture, de la Pe^che et de
l’Aquaculture de Mayotte (CAPAM)’, which is a partner of the DAAF. It provides technical support to
professionals for agriculture development in the territory. Until the end of 2018, CAPAM was in charge
of the animal identification and certification of bovine filiations. However, since the start of the
outbreaks of RVF late December 2018 and the peak observed early 2019, DAAF is now the one taking
care of both activities.
In 2012, a farmer’s cooperative was created in Mayotte from ADEM (a previous farmer’s
association) named COOPADEM. Since 2013, it is designated by the Veterinary Authorities as the
Delegated Health Organisation (‘Organisme a Vocation Sanitaire’, OVS) of Mayotte. In France, OVS is
the regional breeders’ organisations to which national authorities may delegate animal health missions
like the implementation of control and surveillance programmes. COOPADEM is part of SESAM
surveillance system since 2009 and is responsible for the database of RVF in Mayotte since 2012.
In Mayotte, the diagnostic animal health laboratory diagnosis is primarily managed by the
Departmental Veterinary Laboratory located in Mamoudzou that can perform some of the conventional
and routinely asked analyses. More specific and advanced analyses that involve molecular biology
equipment and dedicated reagents essential to confirm the presence of a newly emerged pathogen or
its re-occurrence are carried out in the laboratory facilities of CIRAD (UMR ASTRE) (Agricultural
Research for the Development namely CIRAD) located in Reunion. The UMR ASTRE of CIRAD is
officially mandated by the French Ministry of Agriculture as the French National Reference Laboratory
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21 AGRESTE Mayotte : ETUDES d’Informations Statistiques agricoles menees en 2017 - janvier 2018 (PDF : 3.9 Mo) - 16/2/2018
http://agreste.agriculture.gouv.fr/IMG/pdf/D97618A02.pdf and http://agreste.agriculture.gouv.fr/en-region/mayotte-665/
22 Ministere de l’ Interieure: https://www.interieur.gouv.fr/fr/Archives/Archives-des-dossiers/2018-Dossiers/Mayotte-le-departeme
nt-de-tous-les-defis
23 Direction departementale de l’alimentation, de l’agriculture et de la fore^t of Mayotte http://daaf.mayotte.agriculture.gouv.fr/
and its mission: http://daaf.mayotte.agriculture.gouv.fr/Les-missions-de-la-DAAF,64 and http://daaf.mayotte.agriculture.gouv.
fr/IMG/pdf/SA_cle09bb8e.pdf
24 DAAF Organogram: http://daaf.mayotte.agriculture.gouv.fr/IMG/pdf/Organigramme_general_Services_unites-1_cle85a6b2.pdf
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for RVF and is responsible for the confirmation of the animal cases of RVF detected in the samples
from clinically suspected animals. Moreover, due to the absence of RVF-specific reagents, consumables
and equipment in the Departmental Veterinary Laboratory of Mayotte, most of the samples collected in
the framework of the RVF sero-surveillance programme during the 2018–2019 epizootics were
analysed by CIRAD in Reunion. Due to the distance between Mayotte and Reunion and flights
connections, animal samples are sent on a routine basis of once a week, which may create a short
delay in the early diagnosis of the diseases and the implementation of the control measures.
3.1.5. Animal trade and animal movements
Livestock production is limited in Mayotte. Farmers replace and renew their livestock with locally born
animals or by artificial insemination with semen imported from abroad. Animal import from non-EU
neighbouring countries (e.g. Comoros, Madagascar) to Mayotte is forbidden; this raises the demand for
animals and animal products; thus, animals are mostly imported to Mayotte rather than exported. This
creates a driver for high prices of livestock in Mayotte and consequently for possible illegal introduction
of animals. Live animals are not imported to Mayotte from other European territories because of the
distances and the consequent high cost. The price at slaughterhouse is between €1,800 and €3,100 for
one adult cattle and more than €6,000–7,000 for a dairy cow (DAAF, 2018). A dispatch of 25 cattle was
imported from mainland France in 2008 and another one of 45 cattle in 2018 (COOPADEM). Import of
live animals to Mayotte from other non-EU neighbouring countries is not permitted. Nevertheless,
according to some publications and the information provided by the French Veterinary Authorities, the
police regularly intercept boats that illegally transport ruminants, from the surrounding islands. These
animals are culled, and the carcases destroyed, but in advance, blood samples are collected and stored,
in case of further use. According to the data in Table 4 provided by COOPADEM, it is clear that there is a
frequent uncontrolled trade of animals, even in small numbers. Moreover, in June and August 2018,
recently infected animals, positive for RVFV-specific IgM antibodies, were found among animals that
were illegally moved and seized by the police (Table 4).
Table 2: Numbers of ruminants that arrived in Mayotte and were seized by the police between May
2018 and December 2019 (only for months where uncontrolled movements were
detected)
Cattle Goats Sheep
Month
year
Seized
Tested for
IgG (no.
of pos.)
Tested for
IgM (no.
of pos.)
Seized
Tested for
IgG (no.
of pos.)
Tested for
IgM (no.
of pos.)
Seized
Tested for
IgG (no.
of pos.)
Tested for
IgM (no.
of pos.)
May 2018 0 0 0 4 4 (0) 4 (0) 4 4 (0) 4 (0)
June 2018 2 2 (1) 2 (0) 10 10 (1) 10 (1) 19 19 (9) 19 (9)
August 2018 1 0 0 10 10 (8) 10 (0) 8 8 (8) 8 (2)
September
2018
0 0 0 1 1 (0) 1 (0) 0 0 0
October 2018 3 3 (0) 3 (0) 0 0 0 2 2 (2) 2 (0)
December
2018
1 1 (1) 1 (0) 2 0 2 (0) 2 0 2 (0)
Total 2018 7 6 (2) 6 (0) 27 25 (9) 27 (1) 35 33 (19) 35 (11)
February 2019 1 1 (0) 1 (0) 8 8 (0) 8 (0) 1 1 (0) 1 (0)
July 2019 2 0 2 (0) 1 0 1 (0) 0 0 0
August 2019 4 3 (0) 4 (0) 10 0 10 (0) 4 0 4 (0)
September
2019
1 0 0 5 0 0 1 0 0
October 2019 0 0 0 2 0 0 0 0 0
November
2019
0 0 0 2 2 (1) 2 (0) 5 5 (0) 5 (0)
December
2019
0 0 0 6 6 (1) 6 (0) 0 0 0
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Key points:
• Animals are often illegally transported in Mayotte, thus representing a continuous risk of (re)
introduction of RVF and other diseases.
• There is evidence that at least in June and August 2018, small ruminants recently infected with
RVFV (IgM antibodies were detected) have been introduced into Mayotte.
3.1.6. Historical and recent epidemiological situation of RVF in Mayotte
3.1.6.1. Emergence of RVF in Mayotte in 2007 and surveillance activities
Rift Valley Fever was confirmed for the first time in Mayotte, 7 September 2007, in a 12-year-old
boy who was transferred to Mayotte’s Hospital with a history of severe encephalitis. The young boy
was coming from Moroni (Grande Comore Island, Union of the Comoros) and never travelled outside
Comoros. The onset of symptoms started in May 2007 in Comoros and RVF was diagnosed in Mayotte
by ELISA that identified the presence of RVFV IgM and IgG antibodies (Sissoko et al., 2009).
Following this initial human case detected in Mayotte, sporadic human cases have been reported in
the four islands of the Comoros archipelago in an inter-epidemic or a post-epidemic period, one in
March 2008 (AFSSA, 2008), and two other ones confirmed in 2011–2012 after having travelled to the
Union of the Comoros, one in Mayotte and one in mainland France (InVS, 2011, 2012).
This first case in Mayotte in 2007 stimulated the Veterinary and Public Health Authorities for further
investigation. Several studies were implemented in human and animal populations either
retrospectively in stored samples or prospectively (see Appendix B). Surveillance activities were
initiated in order to monitor and follow up the epidemiological situation in Mayotte. The results are not
strictly comparable because of their different study designs, target populations, laboratory methods.
Sometimes, they were based on the availability of resources (reagents, consumables, staff).
Nevertheless, they can provide a rough estimation on the presence of RVF in Mayotte.
Since September 2007 until March 2008, samples collected from humans with dengue-like illness
who tested negative for Plasmodium spp., chikungunya virus (CHIKV) and dengue virus (DENV) were
screened for RVFV. Recent RVFV infection was identified in 10 samples out of 220 tested (4.5%),
based on the presence of viral RNA detected by RT-PCR (Drosten et al., 2002) or by an in-house IgM-
capture enzyme immunoassays ELISA (Sissoko et al., 2009a). None of these patients travelled to RVF
endemic countries within 3 weeks interval before the onset of the illness. 50% of the cases were in
contact with animals during their work (animal herding, contact with aborted animals, milking,
slaughtering and butchering). 70% of the cases occurred from January to April, during the hot rainy
season (Sissoko et al., 2009a). RVF viruses isolated from samples from two patients, were sequenced
and the results showed that they were related to the 2006–2007 eastern African-Kenya-1 lineage
(Sissoko et al., 2009a; Cetre-Sossah et al., 2012b). Therefore, RVF outbreaks of 2007 in Mayotte
appear to be an expansion of the eastern Africa outbreaks (Sissoko et al., 2009a).
Lernout et al. (2013) carried out a multistage, cluster sampling survey in humans, in different
districts of Mayotte. The individuals were enrolled for a 5-week period (March–April 2011). Serum
samples were analysed by using an in-house indirect ELISA prepared by the National Reference Centre
for Arboviruses (NRC-Arbo) at the Pasteur Institute in Paris. Of the 1,413 human sera, 58 (4.1%) were
detected positive for the presence of RVFV IgG antibodies. The overall weighted seroprevalence of
RVFV antibodies in the general population aged more than 5 years old was 3.5% (95% CI 2.6–4.8).
No significant differences in prevalence were observed when comparing gender or geographical area.
The highest seroprevalences were observed in farmers (32.1%) and persons associated with animal
birthing activity or in contact with aborted animal foetuses (27.8%).
Following the first human case in 2007, Cetre-Sossah et al. (2012a) conducted four serological
investigations on samples collected in Mayotte during the period 2004–2008. The results of these
studies are the following:
Cattle Goats Sheep
Month
year
Seized
Tested for
IgG (no.
of pos.)
Tested for
IgM (no.
of pos.)
Seized
Tested for
IgG (no.
of pos.)
Tested for
IgM (no.
of pos.)
Seized
Tested for
IgG (no.
of pos.)
Tested for
IgM (no.
of pos.)
Total 2019 8 4 (0) 7 (0) 34 16 (2) 27 (0) 11 6 (0) 10 (0)
Numbers of tested and numbers of RVFV-specific IgG and IgM-positive antibodies are provided, respectively (Source: COOPADEM).
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• A first set of samples collected from ruminants on a yearly basis from 2004 to 2007 were tested
for RVFV-specific IgG antibodies and seroprevalence was estimated at 22.7% (n = 130) in 2004
followed by a large decrease in 2005 reaching 3.07% (n = 130) followed by an increase in 2006
and 2007 with 12.3% (n = 130) and 30.9% (n = 126), respectively. Specific RVFV IgM
antibodies were not detectable during this study.
• A second set of samples, consisting of 29 illegally introduced goats and 79 cattle born on
Mayotte and living near the introduced goats, was analysed. Among the goats, RVFV-specific
IgG antibodies were identified in four goats (13.79%) and IgM (6.89%) in two goats suggesting
recent infection. Among the 79 cattle, IgG and IgM against RVFV were found in 29 (37%) and
in 3 (4%) cattle, respectively. A third set of 301 cattle serum samples were collected between
June 2007 and May 2008 from 104 farms in 17 communes of Mayotte. IgG antibodies identified
in 32 cattle (10.6% (95% CI: 7–14%)) indicated the exposure of the animals to RVF. The
positive samples were distributed all over the island.
• A last set of samples, originating from a prospective study of 70 seronegative goats distributed
in five farms and collected every 6 or 8 weeks between August 2008 and August 2009, was
tested for RVF-specific IgM and IgG antibodies. Only one goat (1.43%), located in Bouyouni,
seroconverted in February 2009 and IgM antibodies were detected.
Lernout et al. (2013) performed a prospective longitudinal study where 198 seronegative ruminants
(131 bovines, 67 small ruminants) from 33 sentinel herds were randomly chosen and monthly bled
between March 2010 and August 2011. An overall seroprevalence in the ruminant population was
estimated at 25.3% (95% CI: 19.8–32.2). Prevalence at herd level was 61.9% (95% CI: 44.8–79.2).
No significant difference (p-values < 0.05) was observed between small ruminants 22.4% (95% CI:
14.1–32.2) and cattle 26.8% (95% CI: 19.1–35.3).
In 2009, a surveillance system for animal diseases was initiated in Mayotte (Systeme d’
epidemiosurveillance animale a Mayotte, SESAM), in order to investigate the presence of RVF.25 All the
samples were tested for IgG, while IgM testing was randomly done on a subset of sera samples when
funding was available. Metras et al. (2016) collected the raw data from the studies of Cetre-Sossah
et al. (2012a) and additional data from surveillance activities in the framework of SESAM from May
2009 to June 2015, collated them and proceeded with an analysis of RVF seroprevalence for an 11-
year period (October 2004 to June 2015). They used a data set of 5,720 samples from 3529 animals
of 448 herds. All the samples were tested for IgG, while 26.5% (n = 1,513) were tested for both IgG
and IgM. Given the small size of Mayotte, the whole island was considered as a single epidemiological
unit. Data were aggregated by ‘epidemiological year’ (July–June), in order not to split the rainy season
which is favourable to vectors abundance and RVF outbreaks (see Table 4).
RVF sero-surveillance is still ongoing in Mayotte. For the purpose of this Opinion, the data from the
study of Metras et al. (2016) provided by Dr Metras, Dr Dommergues and Dr Cetre Sossah were
combined with the latest data (2015–2020) of the surveillance on RVF generated in the framework of
SESAM aggregated per epidemiological year following the Metras et al. (2016) methodology. The
results of RVFV IgG and IgM antibodies (estimated sero-prevalence) are presented in Table 4 and in
the graph of Figure 5.
The results of Metras et al. (2016) study from May 2009 to June 2015 are included in Table 4
together with the results of the RVF surveillance the following years.
Table 3: The sero-prevalence of IgG and IgM antibodies of RVF in ruminants (cattle, sheep and
goats), according to the results of the different sero-surveillance activities in Mayotte from
2004 to 2020 per epidemiological year (from July of year y to June of year y + 1). CI,
Confidence Intervals
Epi-year
(July–June)
IgG antibodies IgM antibodies
Tested Positive
Seroprevalence, %
(95% CI)
Tested Positive
Seroprevalence, %
(95% CI)
2004–2005 243 33 13.6 (8.5–18.7) 0 NA NA
2005–2006 22 1 4.5 (. 0–18.3) 0 NA NA
2006–2007 169 20 11.8 (7.1–16.6) 0 NA NA
Rift Valley Fever in Mayotte
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In addition, in the Union of Comoros, a longitudinal survey of livestock was set up in the Comorian
ruminant population from 2010 to 2011, in order to identify the hypothetical source of RVF. The
phylogeographic genomic analysis has shown that RVFV detected in a zebu collected in Anjouan in
August 2011 seems to be related to the last known epidemic of RVF that occurred in East Africa and
Madagascar (2007–2009) (Maquart et al., 2016). This result highlights the fact that RVF has been
maintained within local livestock populations and transboundary animal movements from Eastern
continental Africa to Indian Ocean islands likely resulted in RVFV crossover.
Key points
• The animal population in Mayotte has been exposed to RVFV at least since 2004 or even earlier,
since RVF-specific IgG antibodies were detected in serum samples in 2004. RVFV-specific IgM
antibodies were not identified before 2007 and efforts for virus isolation were unsuccessful.
• Illegal animal movements from the Union of the Comoros was the most likely way of
introduction of RVFV in Mayotte since IgM (recent infection) and IgG (ever infected in the past)
Epi-year
(July–June)
IgG antibodies IgM antibodies
Tested Positive
Seroprevalence, %
(95% CI)
Tested Positive
Seroprevalence, %
(95% CI)
2007–2008 647 111 17.2 (12.09–22.2) 16 3 18.725 (0–44.9)
2008–2009 142 51 35.9 (16.7–55.1) 96 39 40.6 (24.9–56.4)
2009–2010 591 154 26.1 (26. –19.4) 77 28 36.4 (21.5–51.2)
2010–2011 182 26 14.3 (10.3–18.3) 109 4 3. 7 (0.1–7.2)
2011–2012 500 72 14.4 (9.4–19.3) 0 NA NA
2012–2013 645 78 12.1 (8.3–15.9) 0 NA NA
2013–2014 1,253 122 9.7 (7.2–12.3) 576 5 0.9 (0.0–1.7)
2014–2015 462 29 6.3 (2.8–9. 8) 462 0 0
2015–2016 1,798 126 7.2 (6.4–7.6) 1,381 2 0.1 (0.0–0.2)
2016–2017 328 9 2.7 (1.8–3.6) 0 NA NA
2017–2018 559 12 2.1 (1.53–2.8) 3 0 0
2018–2019 1,033 342 33.1 (31.6–34.6) 886 61 6.9 (6.0–7.7)
2019–2020 378 225 59.5 (57–62.0) 207 4 1.9
NA: not tested.
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Figure 5: The seroprevalence of IgG and IgM antibodies of RVF according to the results of the
different sero-surveillance activities in Mayotte from 2004 till 2020 per epidemiological year
(from July of year y to June of year y + 1)
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antibodies were detected in goats illegally introduced to Mayotte from the Union of the
Comoros.
• The first documented introduction of RVF in Mayotte was in 2007, and the responsible virus was
the eastern African-Kenya-1 lineage circulating in East Africa on 2006–2007. This indicates an
expansion of the eastern Africa outbreaks followed by high RVF seroprevalences geographically
distributed all over the island (Cetre-Sossah et al., 2012a).
• The seroprevalence in livestock decreased from 2008 to June 2018, and this suggests the
absence of new virus incursion into the island in this period.
3.1.6.2. Re-emergence of RVF in Mayotte in 2018
The first human case in Mayotte was admitted at the hospital on 22 November 2018, the date
considered as the onset of the symptoms, and RVF confirmed in December, one month later.
In January 2019, RVF was confirmed in animals and notified to the Animal Disease Notification
System (ADNS). Since Mayotte Department is part of French Territory, French Veterinary Authorities
are obliged to notify the RVF outbreaks to the EU ADNS according to the Council Directive 82/894/
EEC. The data on ADNS include only the outbreaks that have been officially confirmed and notified by
the Veterinary Authorities. An outbreak can refer to more than one affected animal even in different
species if they constitute a unique epidemiological unit and are identified at the same location. A
confirmed case is an animal with clinical signs and positive results either in IgM detection or PCR or
both, official confirmed by CIRAD in La Reunion (French Veterinary Authorities, PAFF Committee).
Since then all suspect animals with abortion or flu-like syndrome were tested for RVF.
Two laboratory tests were performed in order to confirm the RVF in ruminants, a commercial IgM
ELISA test (ID Screen RVF IgM Capture, IDVet, France) and a quantitative qRT-PCR based on the L
segment of RVF (Bird et al., 2007).
Until August 2019, 121 outbreaks in ruminants from Mayotte were reported in ADNS, plus four
outbreaks in December 2018 reported by French veterinary services, for a total of 125 outbreaks:
72.8% of the total number of outbreaks concerned only cattle, 14.4% goats, 6.4% cattle and goats,
4% sheep, 0.8% cattle and sheep and 1.6% cattle, sheep and goats. As shown in Figure 6, the
outbreaks are distributed across the whole island. The minimum distance from each outbreak to the
closest one is 30.1 m and the maximum is 2,664.8 m with the median 531 and 25 and 75 quantiles
304.3 and 1,025.9 accordingly.
Rift Valley Fever in Mayotte
www.efsa.europa.eu/efsajournal 23 EFSA Journal 2020;18(4):6093
The epidemiological investigation into disease introduction revealed the illegal imports of live
animals (mainly goats) from the Union of the Comoros during the preparation for the celebration of Eid
al Adha26 of 2018 (22 August 2018) (reported in ADNS, information provided by French Veterinary
Authorities).
The Public Health and Veterinary Authorities frequently published information on the evolution of
the disease both in human and animal population by press releases that were uploaded on the website
of the Regional Agency of Health (Agence Regionale de Sante, ARS)27 in Mayotte and are available to
the public. The information of the evolution of the disease included in these press releases is
presented in Appendix C and in the graph of the Figure 6. A total of 143 human cases were confirmed
between November 2018 and July 2019 (Youssouf et al., 2020).
Figure 6: Geographical distribution of the outbreaks in the animal population (cattle, sheep, goats)
according to the notifications to the ADNS and the additional information of Veterinary
Authorities, December 2018–August 2019
Rift Valley Fever in Mayotte
26 Eid al Adha which means ‘feast of the sacrifice’ is one of the most important religious Islamic fests when animals usually goats,
sheep or cows are sacrificed as an offer to God, and the meat is distributed to the people. https://www.aljazeera.com/news/
2019/08/muslims-celebrate-eid-al-adha-religious-holiday-190811073635616.html; https://www.edarabia.com/eid-al-adha/
27 ARS: les archives des communiques de presse diffuses par l’ARS Ocean Indien en 2019: https://www.lareunion.ars.sante.
fr/communiques-de-presse-de-lars-ocean-indien-2019
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Given the outbreaks of the 2018–2019 epidemic, the serosurveillance was targeted on selected farms
without any clinical signs in cattle. Nevertheless, it is impossible to ensure that the selection of farms was
not biased. Commercial kits were used to identify IgG (previously infected) and IgM (recent infected)
antibodies (ID Screen RVF multispecies competition kit, RVF ELISA IgM capture IDvet, France). The
samples were analysed in the Departmental Veterinary Laboratory of Mayotte when reagents and
consumables were available. In 2018 and 2019, due to the lack of resources, the samples were dispatched
to Reunion to be analysed by CIRAD. The results of RVF surveillance and the seroprevalence of IgG and IgM
antibodies per month in Mayotte are presented in Table 5 and in the graph of the Figure 8 (data from
COOPADEM). The animals in which IgM antibodies were identified did not present clinical signs.
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Figure 7: Cumulated cases of RVF in humans and animals in Mayotte in 2019. Data Source:
Regional Agency of Health (Agence Regionale de Sante, ARS)
Table 4: The results of the RVF sero-surveillance per month in cattle and small ruminants just
before and after the recent RVF epidemic in Mayotte
Month
IgG antibodies IgM antibodies
Tested Positive
Prevalence %
(95% C.I.)
Tested Positive
Prevalence %
(95% C.I.)
Aug-18 48 6 12.5 (7.7–17.3) NA NA NA
Sep-18 131 12 9.2 (6.6–11.7) 1 0 0
Oct-18 0 NA NA NA NA NA
Nov-18 0 NA NA NA NA NA
Dec-18 1 1 100 1 0 0
Jan-19 0 NA NA NA NA NA
Feb-19 443 66 14.9 (13.2–16.6) 442 31 7.01 (5.8–8.2)
Mar-19 113 85 75.2 (71.2–79.3) 144 19 13.2 (10.4–16.0)
Apr-19 0 NA NA NA NA NA
May-19 177 91 51.4 (47.7–55.2) 176 8 4.5 (3–6.1)
Jun-19 120 81 67.50 (63.22–71.78) 122 3 2.46 (1.06–3.86)
Jul-19 177 108 61.02 (57.35–64.68) 180 3 1.67 (0.71–2.62)
Aug-19 38 25 65.79 (58.09–73.49) 12 0 0
Sep-19 157 86 54.78 (50.80–58.75) 15 1 6.67 (0.23–13.11)
Oct-19 6 6 100 (CI) NA NA NA
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Moreover, a recent study on genetic sequencing (Vanhomwegen et al., submitted) has shown that
RVFV circulating in the 2018–2019 epidemics is genetically different from the one in 2008 included in
clade Kenya-1. The RVFV isolated in 2018–2019 is still part of the Eastern African lineages but
considered as reintroduced strains: this supports the fact that the current epidemics is due to re-
introduction rather than RVF persisting in the island.
Key Points
• The most probable way of RVF re-introduction into Mayotte was indicated by the
epidemiological investigations, which revealed illegal imports of live animals (mainly goats) from
the Union of the Comoros during the preparation for the celebration of Eid al Adha of 2018 (22
August 2018).
• Recent genetic study has shown that the RVFV in 2018–2019 epidemic is genetically different
from the one in 2008, thus dealing with a RVFV re-introduction.
• The recent epidemic of RVF lasted 10 months (November 2018 to August 2019) counting 125
outbreaks in animals and 143 human cases.
• The seroprevalence of RVF was high across the whole island in 2019.
• According to the notifications to the ADNS, the RVF outbreaks in 2018–2019 were distributed all
over the island.
3.1.7. RVF impact on animal health and farm production in Mayotte
Morbidity
According to the data submitted to the ADNS and the supplementary information from the French
Authorities, during the recent epizootic 2018–2019, there were 166 cattle, 43 goats and 19 sheep
infected. Based on the data in ADNS and using the animal populations of the census of 2010 for small
ruminants and the latest update of 2017 for cattle, the morbidity in cattle was 0.81% while in small
ruminants was 0.49% (1.89% for sheep and 0.37% for goats).
Mortality
From the data on the outbreaks of the recent RVF epidemic that were notified in the ADNS, only
two deaths in cattle were reported. Based on this information and considering the whole Department
of Mayotte as a unique epidemiological unit, the mortality in the total population of cattle (20,000
heads in 2017) can be estimated at 0.01% and case fatality rate equal to 1.20%.
Figure 8: Seroprevalence of IgG and IgM RVF antibodies, per month in cattle and small ruminants in
Mayotte just before and after the recent RVF epidemics in 2019
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Abortions in animal populations
The number of abortions in Mayotte is usually monitored by the national brucellosis surveillance
programme. Abortions in animals notified after the first human RVF case in 2018 were also tested for
RVF by RT-PCR.
Data on the number of abortions reported by farmers in livestock have been available since 2012 at
the Departmental laboratory (Table 6). On average, 36 abortions were reported each calendar year. In
2019, 199 abortions were reported until November, which is more than a fivefold increase (Figure 9).
The increase can be attributed to RVF epidemics but also to the increase awareness (an awareness
campaign was carried out) due to the recent RVF epidemic.
The number of abortions was:
• for cattle, it was 3.03 times higher than the previous year (2018) and 3.7 times higher
compared to the mean of the previous 7 years.
Table 5: Yearly number of reported abortions in livestock. Source: data from COOPADEM
Cattle Goats Sheep
Year
No
abortions
RVF
tested
RVF positive
in PCR
No
abortions
RVF
tested
RVF
positive
No
abortions
RVF
tested
RVF
positive
Total
tested
2012 9 0 – 1 0 – 1 0 – 11
2013 17 0 – 10 0 – 3 0 – 30
2014 37 0 – 10 0 – 0 0 – 47
2015 32 0 – 10 0 – 3 0 – 45
2016 38 0 – 5 0 – 0 0 – 43
2017 31 0 – 3 0 – 1 0 – 35
2018 32 4 4 3 0 – 2 0 – 37
2019 131 126 79 64 57 32 4 4 4 199
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Figure 9: Number of abortions reported by the farmers per year in Mayotte in cattle, sheep and goats
Source: data from COOPADEM
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• for goats, it was 20.33 times higher than the previous year (2018) and 10.6 times higher
compared to the mean of the previous 7 years.
• for sheep, it was two times higher than the previous year (2018) and 2.58 times higher
compared to the mean of the previous 7 years. In any case, the number of sheep (and reported
abortions) in Mayotte is very small.
In Figure 10, the number of abortions and related PCR positivity is shown per each week in 2019.
As expected, the PCR positives are in the first period of 2019, when the RVF outbreaks were also
reported.
Flu-like syndromes in cattle
The flu-like syndrome (syndrome grippal or bavite) is a pathological entity due to a set of different
pathogens that has been put under surveillance in Mayotte by private veterinarians since 2011.
It is commonly used to describe several clinical signs mainly associated with the diseases that cause
excessive salivation such as Bluetongue (BT), Epizootic Hemorrhagic Disease (EHD) and Bovine
Ephemeral Fever (BEF) (known as 3-day sickness) (French Veterinary Authorities). Even without a
specific aetiology, flu-like syndrome is the most frequent reason for a farmer to call a veterinarian in
Mayotte (Dacheux et al., 2019; Dommergues et al., 2019).
Therefore, COOPADEM implemented a project to investigate the flu-like syndrome in cattle since
2012. The investigation relies on the notification of flu-like syndromes by the vets. From 2015 to 2018,
vets reported nasal discharge in 88% of flu-like syndromes, anorexia in 80%, hyperthermia (above
39.5°C) in 43%, excessive salivation in 32%, lameness in 29% and decubitus in 22%.
Some clinical signs of RVF are very similar to those that are described under the flu-like syndrome.
During the 2018–2019 epidemics, animals with flu-like syndromes were tested only for RVF. RVF was
confirmed positive based either on PCR (Bird et al., 2007) or on RVF-positive IgM antibodies detection
(RVF ELISA IgM capture, IDvet) by CIRAD, Reunion in 34 flu-like syndromes samples out of the 117
tested, in 2019 (Table 7 and Figure 11 for reported flu-like syndrome weekly in 2019). Techniques
used to diagnose BTV, EHDV and BEFV are detailed in Dommergues et al. (2019) and Dacheux et al.
(2019).
Figure 10: Number of reported abortions in livestock since the first human confirmed RVF case with
RVF RT-PCR results. Week number 49 starts on 3 December 2018. Week number 28 in
2019 (8–14 July)
Rift Valley Fever in Mayotte
www.efsa.europa.eu/efsajournal 28 EFSA Journal 2020;18(4):6093
Milk production case study in a dairy farm in Mayotte
Data on milk production for one farm raising mainly crossbred cattle in Mayotte were used. Records
on weekly milk production (litres per week) from 2015 to 2019 and the number of lactating cows each
week were available.
This farm was affected by RVF in January 2019; RVFV was laboratory confirmed on 23 January
2019. Abortions were reported on 8th, 11th, 13th, 18th of February. In previous years, abortions were
recorded in 2016 and 2017, but none in 2018. Flu-like syndrome was reported on 8 February in a
different cow than the one which aborted. The previous cases of flu-like syndrome were reported in
2018. Lactating cows were blood sampled on 2 February and three out of five were IgM positive, while
four out of five were IgG positive. All cattle present in the farm older than 1-year old were blood
sampled on 18 June, 1 out of 38 was IgM positive, while 20 out of 38 were IgG positive (52.6%).
The aim of this analysis was to verify the possible variation of the milk production due to the RVF
outbreak in early 2019. To this end, the rate of milk production in 2019 was compared with that
observed during the reference period from 2015 to 2018. The Table 7 below summarises the median
values of the weekly milk production in the years under study and the mean number of lactating
animal present.
Table 6: Reported cases of flu-like syndromes in cattle, Mayotte, 2012–2019 including results of
bluetongue (BTV), epizootic hemorrhagic disease virus (EHDV), bovine ephemeral fever
(BEFV) and RVFV genome detection.￼ NT, Not tested
Year
Flu-like
syndromes
Tested
for BTV
Positive
BTV no.
(%)
Tested
for EHDV
Positive
EHDV no.
(%)
Tested
BEFV
Positive
BEFV no.
(%)
Tested
RVFV
Positive
RVFV no.
(%)
2012 15 NT NT NT NT NT NT NT NT
2013 14 NT NT NT NT NT NT NT NT
2014 35 15 3 (20) 0 NT 0 NT 0 NT
2015 48 26 8 (30.7) 26 8 (30.7) 0 NT 5 0
2016 60 43 12 (27.9) 43 21 (48.8) 0 NT 0 NT
2017 19 17 4 (23.5) 17 5 (29.4) 10 4 (40) 0 NT
2018 29 27 6 (22.2) 27 8 (29.6) 0 NT 1 1
2019 122 0 NT 0 NT 0 NT 117 34 (29)
Figure 11: Weekly reported cases of flu-like syndromes in cattle in 2019
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From Table 7, the production loss per cow per week in 2019 compared to the reference period of
2015–2018 is about 18% (60.7–49.6/60.7 9 100 = 18%).
A rough comparison of Figure 12 shows that the milk production in 2019 follows the same trend
over the weeks compared to that in the reference period with weeks of low milk production at the
beginning and ¾ of the year. However, the milk production from week 27 to week 41 in 2019 is below
the lower bound of the reference period 2015–2018. The detailed milk production in 2015–2018 and in
2019 per each week with related number of dairy cows present each week in the farm studied and the
deviation of milk production in 2019 from expected production in the reference period (2015–2018)
shown per week is reported in Appendix E.
This finding could be related to the reproductive perturbations given by the RVFV infection, which
can be various according to the period of pregnancy during which the mother is infected. Abortions
can be expected when the infection occurs in the second half of the pregnancy. Foetal resorption can
be observed in case of infection in the first stages of pregnancy. If we consider that the RVF epidemics
in Mayotte had a peak between February and April 2019, then according to the pregnancy period in
Table 7: Number of dairy cows (mean with CI 95%) and milk production rate (median with CI
95%)
Year
No. dairy cows: mean
[CI : 2.5%; 97.5%]
Milk production rate (L/cow/week):
median [CI: 2.5%; 97.5%]
2015 10 [8; 12] 58.9 [40.4; 85.6]
2016 10 [8; 11] 57.3 [46.2; 67.8]
2017 9 [8; 11] 63.8 [47.2; 87]
2018 9 [7; 11] 59.6 [47.9; 80.3]
2015–2018 10 [7; 11] 60.7 [45.9; 85.8]
2019 8 [6; 9] 49.6 [29.1; 67.3]
Figure 12: Weekly milk production during the reference period 2015–2018 and in 2019. For each
week, the blue line represents the median and the grey shadow represents the range
given by 2.5% and 97.5% percentiles for the reference period 2015–2018. Purple squares
correspond to production rate in 2019. Horizontal dashed lines correspond to the median
(red), 2.5% and 97.5% percentiles (blue) of the overall reference period 2015–2018
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which animals aborted, a milk drop can be expected from 2 to 4 months after the infection (animals
aborted in mid-late stage of pregnancy) until almost 9 months for animals infected in the early stages
of pregnancy.
Considering the value of milk reduction due to RVFV infection as assessed by the above study
(18%), two possible estimates of the total economic losses in Mayotte in 2019 due to milk drop may
be calculated:
• Considering that all animals present in the outbreaks (n = 1,060) experienced an effect on the
milk production, the total loss would be equal to €1,221,120.
• Considering that only animals affected by the disease as notified in ADNS (n = 166) experienced
an effect on the milk production, the total loss would be equal to €191,232.
Key points:
• The official mortality rate in RVF outbreaks, as notified to ADNS, was equal to 0.01%.
• In 2019, the number of abortions reported in ruminants was fivefold greater than years before.
The majority of the aborted foetuses tested for RVF was positive by PCR.
• Weekly milk production rate, as recorded in one study dairy farm, showed in 2019 from week
29 to week 41 levels of production below the lower bound (2.5% percentile of the production),
as calculated for 2015–2018 period and a general milk loss of 18%. In monetary terms, this
corresponds to €191,232 lost, if only the affected animals as notified in ADNS (n = 166) are
considered. Nevertheless, this result is affected by a large limitation given that it comes from
extrapolating data from one single farm to the whole country.
3.2. Assessment of the probability of RVF overwintering in Mayotte
Mayotte system for RVFV circulation consists of animal hosts and mosquito vectors both present all
year round. Because of weather conditions in Mayotte, the transmission of RVFV is likely to occur all
year round in Mayotte, with differences in vector abundance linked to the rainy and dry season.
Therefore, the overwintering question in Mayotte system is posed in terms of how long the RVFV
infection can persist in such a context in the absence of any introduction. In the following section, the
persistence mechanisms of RVF in Mayotte are assessed.
RVF can persist and overwinter either (i) in the host populations due to a low level circulation of
the virus, or due to additional mechanisms, such as transplacental transmission or the permanence of
live virus in organs or tissues of animal hosts (i.e. the establishment of a long-lasting carrier state) or
(ii) in the vector population through vertical transmission.
3.2.1. Persistence in animal hosts
In the case of RVF, the permanence of the infection through transplacental transmission in animal
hosts is considered rare and there is no known carrier state in mammals (EFSA, 2005). Also, the quite
short viraemic period does not allow the virus to survive and be infectious for a prolonged time in
animal hosts (EFSA AHAW Panel, 2020).
However, susceptible hosts, domestic or wild, can support a low-level virus circulation during the
inter-epidemic periods, especially in the climatic conditions of Mayotte, which allow the presence of
active mosquitoes all through the year.
The persistence of the infection in wild ruminant populations, like springbok, wildebeest and impala, with
sporadic spill over into domestic species, had been observed in some countries of eastern and southern Africa
(Evans et al., 2008; Olive et al., 2012; Rostal et al., 2017). However, the role of wild population in the
maintenance of the infection during the inter-epizootic periods has been proved only in those African areas
with relevant numbers of these animals, like the Kruger or the Etosha Parks in South Africa and Namibia,
respectively (Dondona et al. 2011; Beechler et al., 2015). The absence of any significant wild ruminant
population in Mayotte indicates the possibility of the persistence of the infection in the wild hosts as very
unlikely.
Evidence of virus circulation at low levels in the domestic ruminant population was observed in
West and East Africa (Sumaye et al., 2013; Rissmann et al., 2017). It is not possible to directly assess
the importance of this persistence mechanism for Mayotte, although the progressive reduction of
serological prevalence observed after the 2007–2008 epidemic, until 2018, is suggesting the absence
of any detectable virus circulation in the domestic ruminants during the inter-epizootic period. This
possible persistence mechanism, however, is analysed more in detail in the section 3.2.3.
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3.2.2. RVF persistence through vectors
Information of main vector species was used to assess the possible spread of RVFV to other
territories (i.e. Reunion and mainland France). We also assessed the main vector species present in
Reunion to compare the similarity of vector species to those found in Mayotte.
3.2.2.1. Vector abundance and activity in Mayotte and Reunion
In the following section, we summarised information for each of the potential vector species in
Reunion and Mayotte Islands on mosquito presence, abundance, evidences for RVFV transmission,
host preference and breeding sites.
The mosquito systematics follow Wilkerson et al., 2015 (genera taxa; subgenera is not included
intentionally in the species name for simplification). For field or laboratory evidence of RVFV
transmission, we followed the review of Linthicum et al. (2016), updated when new evidence was
available from recent literature.
In general, 50 species of mosquitoes have been related to the transmission of or competence for
RVFV either by field or laboratory evidences (see (Linthicum et al., 2016)). Most of the species belong
to Culex and Aedes genera.
According to the assessment, there are 47 species of mosquitoes in Mayotte and 13 in Reunion
belonging to five genera (Aedes, Anopheles, Culex, Eretmapodites and Mansonia) (Balenghien et al.,
2013; Le Goff et al., 2014; AFSSA, 2008)) (Table 8).
For the abundance of vector species in Mayotte, we followed the information provided by Le Goff
et al. (2014) and AFSSA (2008). In Le Goff et al. (2014), only immature stages were sampled in
different habitats. Authors categorised abundance of the mosquito species of Mayotte according to its
frequency of presence in the different breeding habitats sampled in the island. The so-called ‘Principal
Species’ were those that were present in ≥ 20% of the habitat that were sampled. Those species were
Ae. aegypti, Ae. albopictus, An. gambiae and E. subsimplicies. Only the three former ones have been
so far related to RVFV transmission either by field or laboratory evidence, but it is known that
An. gambiae play a minor role. For assessing the abundance in Reunion, we followed the information
provided by AFSSA (2008) and Balenghien et al. (2013). In this case, Ae. albopictus, Cx. pipiens,
Cx. quinquefasciatus are considered the most abundant species. In the case of Ae. albopictus and
Ae. aegypti, current control methods after chikungunya and dengue epidemics in Reunion contributed
to limiting its abundance.
Genus Aedes
Ae. aegypti: this species is found in Reunion and Mayotte. It is considered as one of the major
vectors of RVFV since the virus has been isolated from field specimens in Kenya (1956) and Sudan
(2007–2008) and in laboratory transmission assays. This species is found in the rural and urban
environments and is highly anthropophilic. Due to current control programmes after epidemics of
dengue and chikungunya in Reunion, it is considered to play a minor role in epizootic/epidemic
episodes of RVFV since the current population of Ae. aegypti in Reunion is restricted to sylvatic areas
(AFSSA, 2008). In Mayotte, it is considered a widespread and abundant species (AFSSA, 2008). The
breeding sites in Mayotte for this species are diverse, such as holes in rocks, vegetal debris, large
artificial containers and man-made containers. The species included in subgenus Aedimorphus,
Neomelaniconion and Stegomyia are considered to be capable of transmitting RVFV by vertical
transmission (Tantely et al., 2015; Linthicum et al., 2016), however, this phenomenon still requires
confirmation for most of the species involved in RVFV transmission (Lumley et al., 2017). This species
is frequently found in airplanes (Iba~nez-Justicia et al., 2017a,b; Le Maitre and Chadee, 1983; Ammar
et al., 2019). It is considered a mammalophilic and a highly anthropophilic species (REF).
Ae. albopictus: this species is present in Mayotte and Reunion. It is present in urban and rural
areas, associated with small containers where females oviposit (Medlock et al., 2012). It is considered
a potential vector for epizootic/epidemic episodes of RVFV according to the risk assessment conducted
by AFSSA (2008) (EFSA, 2013); however, there is no data of the isolation of RVFV from adults
collected at field level. The rate of infection for Ae. albopictus in laboratory was found to be between
19% and 37% (AFSSA, 2008). According to the survey conducted by CIRAD on mosquito species in
Mayotte and Reunion,28 it is present in the three locations of Mayotte (Figure 14) and widespread in
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Reunion (Figure 15) where it was the major vector of Chikungunya (Delatte et al., 2008). It is
considered a mammalophilic and a highly anthropophilic species (Delatte et al., 2010).
Ae. circumluteolus: This species is a vector for RVFV in East Africa and Southern Africa.
According to AFFSA (2008), this species has a small presence in Mayotte and is absent in Reunion.
This species belongs to the subgenus Neomelaniconion that includes several species of African origin
and major vectors of RVFV such as Ae. (Neo.) palpalis s.l. and Ae. (Neo.) macintoshi. Ae.
circumluteolus is considered a major vector for epizootic episodes in other RVFV endemic African
countries, confirmed by field and laboratory evidence of its role in the transmission of RVFV. This
species is known to breed in temporary grassland depressions (dambos) particularly after heavy rains
in other parts of Africa (i.e. Kenya) (Davies et al., 1985). It is considered a mammalophilic species
(Jupp and McIntosh, 1987).
Ae. fowleri: This species is present in Mayotte and Reunion. Ae. fowleri is included in the
subgenus Aedimorphus that includes Ae. dalzieli, Ae. ochraceus and Ae. vexans that are field vectors
of RVFV in mainland Africa. There are RVFV field isolations that incriminate this species as vector of
the disease (Table 8). There is little information about this species in Mayotte according to Le Goff
et al. (2014) and in Reunion is considered a very rare species (AFSSA, 2008). Its breeding is mainly
restricted to water ponds and pools. It is not considered as an abundant species (Le Goff et al., 2014)
and therefore, plays a minor role in epizootic/epidemic episodes. It is known to be a mammalophilic
species (Fontenille et al., 1998).
Genus Anopheles:
An. coustani: This species is present in Reunion and Mayotte. RVFV have been isolated from field
specimens in Zimbabwe 1969; Kenya 1978; Sudan 2007 and Madagascar 2008, 2009 (Ratovonjato
et al., 2010) (Linthicum et al., 2016) and from laboratory infections. Its abundance is considered
medium–high. The breeding sites for this species in Mayotte are slow flowing water, holes in ground
and marsh and swamp water (Le Goff et al., 2014). This species feed predominantly in mammals,
including humans (Tantely et al., 2013a). Long-distance migration (i.e. active movement not just
passive movement favoured by wind streams) has been attributed to An. coustani in the Sahel area
(Huestis et al., 2019). From a study conducted in Sudan, one larva resulted positive to RVFV (Seufi
and Galal, 2010); however, its role in maintenance of the virus is uncertain.
An. gambiae: This species is present in Mayotte but not in Reunion. There are few references that
link this species with the transmission of RVFV, basically one isolation of the virus from field specimens
in Sudan (Seufi and Galal, 2010; Linthicum et al., 2016), and it is not considered a potential vector of
RVFV in Mayotte (AFSSA, 2008). RVFV has been isolated from larvae and males of this species, but its
possible role in the maintenance of the virus is unclear. This species has been found in ships and
airplanes and has colonised other areas apart from Africa, such as Brazil (Tatem et al., 2006; AFSSA,
2008). Preferred hosts of this species are mammals, including humans, and it is one of the major
vectors of malaria in Africa.
Genus Culex
Cx. pipiens: this species is present in Mayotte and Reunion and according to Balenghien et al.
(2013) is located at North latitudes of Mayotte. It is a species known to be very abundant in urban and
rural areas (it is one of the most important vectors for transmission to humans, including urban/peri-
urban areas) and therefore is commonly related to RVFV epizootic episodes, e.g. in Egypt (Meegan
et al., 1980; Turell et al., 1996). The role of Cx. pipiens in the transmission of RVFV has been
confirmed both in the field and laboratory (Table 8). Culex pipiens is considered to include two
ecoforms Cx. pipiens form pipiens considered to be highly ornithophilic, and Cx. pipiens form molestus
considered to be mammalophilic and ornithophilic (Brugman et al., 2018). Recently, it was showed that
the two forms of Cx. pipiens and even the hybrid forms are susceptible to RFVF infection (Brustolin
et al., 2017). Differently to Aedes species, its contribution for the overwintering of the virus is
considered to be nil due to the incapacity of eggs to stand long periods of desiccation. This species
breeds in a wide type of habitats, from artificial ponds to water flooded areas, including natural and
agriculture ones (Becker and Weitzel, 2012).
Cx. quinquefasciatus: this species is present in Reunion and Mayotte. According to Balenghien
et al. (2013) is located at the South latitudes of Mayotte. It is mainly located in urban and peri-urban
habitats in high abundance (AFSSA, 2008) and it is also considered as the principal vector of Bancroft
filaria on Mayotte (Le Goff et al., 2014). There is field and laboratory evidence (Moutailler et al., 2007)
of RVFV transmission by this species, e.g. in Madagascar in 1979 (Clerc et al., 1980); however, it is
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considered to have a moderate vector competence for RVFV. Due to its widespread distribution and
abundance, it is considered a major vector of epizooties of RVFV. This species is also one of the most
frequently found in planes coming from Africa (AFSSA, 2008). Cx. quinquefasciatus is an opportunistic
blood feeder and was one of the most abundant species collected on humans and sheep (Balenghien
et al., 2013).
Cx. antennatus: this species is present in Mayotte but not in Reunion. It has been related to
RFVF transmission with both field and laboratory evidence and it is considered a very susceptible
species to RVFV (Hanafi et al., 2011). Cx. antennatus is known to be a vector species of RVFV in
Madagascar (Ratovonjato et al., 2010) and in general when present, it is a very abundant and widely
distributed mosquito (Hanafi et al., 2011). It is considered an anthropophilic mosquito (Gad et al.,
1995), and according to Balenghien et al. (2013), it is abundant in mammal host-baited traps in
Mayotte; therefore, it is considered a bridge species between animals and humans. Breeding habitats
of this species are flooded areas, rice fields and irrigation channels, and tolerant of brackish conditions.
Is also considered a frequent species in airplanes (Iba~nez-Justicia et al., 2017a,b).
Cx. bitaeniorhynchus: this species is only present in Mayotte in low abundance and is absent
from Reunion. It has been related to RVFV field transmission in Kenya (Linthicum et al., 2016). It is a
mammalophilic mosquito including feeding on humans (Sahu et al., 2019). This species breeds in
water bodies, such as ponds and pits.
Cx. simpsoni: this species is found in Mayotte but not in Reunion. RVFV was isolated from a pool
of this species and others in Madagascar in 1979 and Kenya in 1982 (Balenghien et al., 2013;
Linthicum et al., 2016). According to Le Goff et al. (2014), this species breeds in water ponds, pools,
marsh and swamp water in Mayotte.
Cx. tritaeniorhynchus: this species is found in Reunion but not in Mayotte. It is an abundant
species, e.g. in Madagascar. This species has been related to field transmission of RVFV in Madagascar
(Jean Jose Nepomichene et al., 2015) and the Arabic peninsula, as well as to laboratory transmission
(Linthicum et al., 2016). Cx. tritaeniorhynchus shows feeding preference for mammals, including
humans and can be considered one of the major vectors due to its abundance (Tantely et al., 2015). It
is also a mosquito species that has been intercepted in airplanes (Haseyama et al., 2007). In Mayotte,
this species is known to breed in marsh and swamp water.
Cx. univittatus: this species is found in Reunion but not in Mayotte. The transmission of RVFV for
this species has been shown from field-collected specimens, for example in Madagascar (Balenghien
et al., 2013), and Kenya (Linthicum et al., 2016; Sang et al., 2017) and it is considered as a secondary
vector (Tantely et al., 2015) due to its medium–high abundance (Tantely et al., 2013b). Rice fields are
the breeding habitat for this species (Nicolas et al., 2014). Its feeding preferences include mammals,
humans and birds.
Genus Eretmapodites
E. quinquevittatus: this species is reported in Mayotte but not in Reunion. There is field evidence
of transmission of RVFV in South Africa in 1971 and in Kenya in 1981–1984 (Linthicum et al., 2016).
Laboratory evidence showed that this species develops low to moderate rates of infection of RVFV. It is
a mammalophilic species that was found to be abundant in mosquito collections made by using
humans and sheep baited traps (Balenghien et al., 2013). Breeding habitats for this species in Mayotte
are snail shells and disposed solid waste (Le Goff et al., 2014).
Genus Mansonia
M. uniformis: this species is present in Mayotte but not in Reunion. RVFV has been isolated from
specimens and/or pools in Kenya (1997–1998, 2006), Madagascar (1979), Mauritania (1987–1988 and
2003), Uganda (1959), Senegal (2003) (Linthicum et al., 2016). There is no experimental information
for this species. It is considered abundant in Madagascar showing preference for mammals, including
humans and being a potential vector of RVFV (Tantely et al., 2015). The breeding habitats for this
species are extensive swamps but differ from other mosquito species since the larvae are generally
submerged and anchored by the siphon to aquatic plant roots from where they obtain oxygen
(Appleton and Sharp, 1985; Le Goff et al., 2014).
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Figure 13: Spatial distribution of Aedes aegypti and Culex quinquefasciatus in Mayotte.
Source https://www.mosquito-maps-oi.fr
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Figure 14: Spatial distribution of Aedes aegypti and albopictus in Reunion. Source https://
www.mosquito-maps-oi.fr
Table 8: Species of mosquitoes present in Mayotte and Reunion
Mayotte Reunion RVFV Vector
Aedes
Ae. aegypti + + FI, LI, LT, MT
Ae. albocephalus +
Ae. albopictus + + LI, LT
Ae. bromeliae +
Ae. cartroni +
Ae. circumluteolus + FI, LI
Ae. dufouri +
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Mayotte Reunion RVFV Vector
Ae. fowleri + + FI
Ae. monetus +
Ae. pia
Ae. simpsoni +
Ae. vittatus +
Anopheles
An. arabiensis +
An. comorensis +
An. coustani + + FI, LI
An. funestus +
An. gambiae + FI
An. maculipalpis +
An. merus +
An. mascarensis +
An. pretoriensis +
Culex
Cx. antennatus + FI, LI
Cx. bitaeniorhynchus + FI
Cx. carleti +
Cx. cinerellus +
Cx. comorensis +
Cx. decens +
Cx. horridus +
Cx. insignis +
Cx. pipiens + + FI, LI, LT, MT
Cx. quinquefasciatus + + FI, LT
Cx. nebulosus +
Cx. simpsoni + FI
Cx. tritaeniorhynchus + FI, LI
Cx. univittatus + FI, LT
Cx. wiggleworthi +
Eretmapodites
E. quinquevittatus + FI, LI, LT
E. subsimplicipes +
Ficalbia
F. grjebinei +
Lutzia
L. tigripes + +
Mansonia
M. uniformis + FI, LI
Mimomyia
M. grjebinei +
Orthopodomyia
O. arboricollis +
O. comorensis +
O. joyoni +
Uranotaenia
U. alboabdominalis +
U. andavakae +
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Key messages:
• RVFV vectors are abundant in Mayotte and Reunion and adults can survive all year round.
• There are 47 spp. of mosquitoes recorded in Mayotte, from which 13 are considered vectors or
potential vectors.
• There are 13 spp. of mosquitoes recorded in Reunion, from which 8 are considered vectors or
potential vector of RVFV.
• There are no studies conducted in Mayotte and Reunion about field isolation of RVFV from
potential vector species.
• The most important species for potential RVFV transmission in Mayotte and Reunion according
to its wide distribution, abundance and vector competence for RVFV are Cx. antennatus, Cx.
pipiens, Cx. quinquefasciatus, Cx. tritaeniorhynchus, An. coustani and E. quinquevittatus.
• There is evidence that current control measures against Ae. aegypti and Ae. albopictus in
Reunion limit their population and as a consequence, its role as vectors of RVFV.
3.2.2.2. Persistence of RVFV in the vectors via vertical transmission
Vertical transmission is defined as the transmission of an arbovirus from an infected female
mosquito to its offspring (Lequime and Lambrechts, 2014). The most effective mechanism of vertical
transmission is transovarial transmission (TOT) where the germinal tissues of the female mosquito are
infected by the virus, and therefore, the laid eggs contain virus particles that can viably persist. The
next generation of adults will be infective since the virus persisted during the whole development from
egg, larva, pupa and finally adult. Therefore, vertical transmission is a natural mechanism of
overwintering that allows persistence of the virus from one year to another, when vectors or hosts are
absent or in low abundance. Vertical transmission is present in many public health significance
arbovirus (i.e. Dengue); however, prevalence is usually low (< 0.1%) and cannot be considered a
common phenomenon (Lequime and Lambrechts, 2014), in addition to that, negative results of vertical
transmission are in general under reported and this can drive a general overestimation of vertical
transmission.
Some species of mosquitoes overwinter as adults, such as Culex spp. and Anopheles spp., while for
other species, as for example Aedes spp., the diapause eggs are the stage that survives winters or
harsh periods such as drought. The diapause eggs can allow the persistence of pathogens through
vertical transmission. This phenomenon depends on the pathogen and the vector species, e.g.
Chikungunya virus is considered to be poorly transmitted to eggs and available data about vertical
transmission are variable, including positive and negative detection of vertical transmission in eggs
(Mourya, 1987; Hailin et al., 1993; Vazeille et al., 2009; Bellini et al., 2012; Delatte et al., 2008a).
Dengue virus is known to be vertically transmitted, but its role for the persistence of the virus at local
and regional level is also considered to be less important than asymptomatic and viraemic humans
(Grunnill and Boots, 2016). In addition, species in the Culex genus are associated with significantly
lower rates of vertical transmission compared to species of the Aedes genus (Lequime et al., 2016).
The pathogenic effect of the virus in the females and/or eggs is considered as a possible explanation
of the difference of vertical transmission among insect-transmitted viruses (Bellini et al., 2012).
It is acknowledged that RVFV-infected eggs can resist for several years until favourable
environmental conditions, usually related to heavy rains, allow hatching. Therefore, Aedine species
Mayotte Reunion RVFV Vector
U. comorensis +
U. douceti +
U. laffosseae +
U. mayottensis +
U. pandani +
Zavortinkius
Z. brunhesi +
Z. monetus +
It is indicated whether RVFV was isolated in any country from field collected specimens (FI); infected in laboratory conditions
(LI); transmitted in laboratory conditions (LT) and transmitted mechanically (MT). Adapted from AFFSA (2008), Le Goff et al.
(2014), Linthicum et al. (2016) and Brustolin et al. (2017). Subgenus is not included. Genus and Species are listed in alphabetical
order without considering Subgenus.
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start RVFV endemic transmission among mammal hosts (including domestic and wild fauna). Epidemics
occur when Culex spp. proliferate in high density in the same flood areas and increase transmission of
RVFV to animals and/or humans (Linthicum et al., 2016).
Up to now, vertical transmission of RVFV has been reported only three times: from Kenya in
Ae. mcintoshi (Linthicum et al., 1985, originally reported as Ae. lineatopennis) from a total of 31,844
pooled field collected specimens. It was also reported in the same species from five specimens after
inoculating RVFV intrathoracically. Finally, in Sudan, RVFV was detected in males of Aedes vexans and
Culex quinquefasciatus by RT-PCR but not virus isolation (Mohamed et al., 2013) from a total of 398
and 1,200 specimens, respectively (Table 9). From the above-mentioned species, only Cx.
quinquefasciatus is present in Mayotte and Reunion; however, Culex spp. are not considered the best
candidates for vertical transmission of RVFV since their eggs are not able to resist long periods of
desiccation.
From the potential vector species of RVFV present in Mayotte and Reunion from the genera Aedes,
Culex and Eretmapodites (Table 9), vertical transmission of RVFV has not been detected in any of
those species when present in other RVFV endemic countries in Africa (i.e. Sudan, Kenya, South Africa)
(Table 9). Detection of vertical transmission was negative either from 4,762 field collected specimens
(including males, eggs, larvae and pupae) and from 7,186 specimens used for laboratory trials (Lumley
et al., 2017) in those countries for the above-mentioned RVFV vector genera.
Sumaye et al. (2019) used the field values of vertical transmission of Ae. mcintoshi obtained from
Linthicum et al., 1985 in Kenya (i.e. range of vertical transmission 0–8.5%) to model the transmission
dynamics of RVF with data collected in the Kilombero Valley in Tanzania. Simulations indicated that the
vertical transmission role of two vector species, Ae. aegypti and Ae. mcintoshi, was not sufficient to
explain inter-epidemic transmission of RVFV in the area. Authors suggested that the role of vertical
transmission is underestimated considering the only reference data available.
Based on the available evidence, it is not possible to confirm the role of the potential species of
Mayotte and Reunion for the persistence of RVFV from one year to another. There is a lack of data of
the possible vertical transmission of RVFV mosquito vector species in Mayotte and Reunion.
Furthermore, none of the species of vectors present in the islands and also in the African continent
have shown vertical transmission, despite the number of specimens from field or laboratory trials
analysed. The majority of the main potential vectors species identified in Mayotte belong to the genus
Culex (see Section 3.2.2.1), from which vertical transmission of RVFV is assumed to be very low (if
present), since Culex spp. eggs are not able to withstand long periods of drought. In addition,
transmission dynamics models also confirmed that the limited evidence available about vertical
transmission of RVFV in mosquitoes does not support an inter-epidemic transmission with the
prevalence of vertical transmission known from countries such as Kenya. Therefore, it can be
concluded that if present, the role on persistence of RVFV in Mayotte and Reunion due to vertical
transmission seems to be of minor relevance compared to other pathways of re-introduction, such as
animal movement from RFVF-infected areas. However, there is high uncertainty since analysis of
vertical transmission in large numbers of some of the major vector species (i.e. Aedes spp.) remains
mostly unexplored in Africa and the territories of concern for this opinion.
Table 9: Species of mosquito vectors of RVFV present in Mayotte and Reunion and for which
vertical transmission (transovarial transmission – TOT) has been tested, in RVFV endemic
countries either in specimens collected from the field or in lab (The technique used for
virus detection is also indicated: AM: orally infected animal model, PA: plaque assay; RT-
PCR: real-time polymerase chain reaction. Information extracted from Lumley et al., 2017)
Countries
# Field
specimens tested
# Lab specimens
tested
Technique and
(+)/(–) to RVFV
Aedes
Ae. aegypti Kenya 745 AM (–)
Kenya 759 PA (–)
South Africa 2,811 AM (–)
Ae. fowleri Senegal 721 AM (–), PA (–)
Total 745 4,291
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3.2.3. Epidemiological models explaining RVF persistence in Mayotte
Two modelling studies have explored the persistence of Rift Valley fever virus (RVFV) in Mayotte
(Cavalerie et al., 2015; Metras et al., 2017). Here, persistence is defined as the virus being present
over time in any hosts or vectors. Both studies considered Mayotte to comprise a single livestock
population, so they did not distinguish between cattle, sheep and goats in terms of RVFV transmission
nor allow for the spatial location of hosts (i.e. the island was treated as a homogeneously mixed
population of hosts and vectors).
The first study used a stochastic compartment model to describe the dynamics of RVF in livestock
and in the aquatic larval and adult stages of the mosquito vectors (treating all mosquito species as a
single population) (Cavalerie et al., 2015). Seasonality in vector abundance was incorporated using a
sinusoidal function for adult emergence with a period of 1 year to capture the wet and dry seasons on
Mayotte. The model was parameterised primarily using estimates from the published literature.
However, the probabilities of transmission from host to vector, of transmission from vector to host and
of vertical transmission in the vector were calculated based on the estimated values for potential RVFV
vector species weighted according to their relative abundance in mosquito catches at five farms on
Mayotte. In addition, the transmission rates were fine-tuned by fitting the model to IgG prevalence
data. The results of the model indicated that the probability of RVFV persisting (defined as virus being
present in any livestock host or larval or adult vector) in Mayotte for 1 year was 25.5%, for 5 years
was 9.5% and for 9 years (the maximum simulated) was 2.1% (see Figure 8 in Cavalerie et al.
(2015)).
The second study used an age-structured stochastic compartment model to describe the dynamics
of RVF in livestock (Metras et al., 2017). The normalised difference vegetation index (NDVI) was used
as a proxy for the vector dynamics, with the transmission rate between hosts being a function of
NDVI. The model also explicitly included the introduction of RVFV to Mayotte through importation of
infected animals. Parameters related to host demography were computed from data on the livestock
population in Mayotte, while those related to RVFV transmission were estimated by fitting the model to
age-specific IgG prevalence data. The results of their model suggest that RVF cannot be sustained in
the ruminant population in Mayotte and the disease dies out by 2010 in almost all replicates once
imports stop in 2009 (see Figure 4 in Metras et al. (2017)). More precisely, once importation of RVFV-
infected animals stopped, the virus was predicted to persist (defined as virus being present in any
hosts) until 2016 in only 0.26% of simulations. This may be because of natural fade out in a relatively
small population, but neither study explicitly shows this.
The two studies came to contrasting conclusions about the probability of RVFV persisting in
Mayotte. Cavalerie et al. (2015) concluded that their results supported the hypothesis (proposed by
Lernout et al., 2013) that RVF is endemic in Mayotte. It is worth noting, however, that the authors
predicted that around 75% of epidemics would last less than 1 year and 90% of epidemics would last
less than 5 years. By contrast, Metras et al. (2017) concluded that there was a very low probability of
RVFV persisting in Mayotte, if it is treated as a closed population (i.e. there are no imports of infected
livestock or vectors). The key difference between the two studies is that Cavalerie et al. (2015)
assumed there was vertical transmission of RVFV in mosquitoes, while Metras et al. (2017) did not
Countries
# Field
specimens tested
# Lab specimens
tested
Technique and
(+)/(–) to RVFV
Culex
Cx. antennatus Kenya 112 AM ()
Cx. pipiens Kenya 114 AM ()
Cx. quinquefasciatus Sudan 1,200 RT-PCR (+)
Cx. univittatus Kenya 44 AM ()
South Africa > 218 AM ()
Total 1,358 330
Eretmapodites
E. quinquevittatus Kenya 2,659 AM ()
South Africa 1,280 AM ()
South Africa 1,285 PA ()
Total 2,659 2,565
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include this route of transmission in their model. This most likely accounts for the probability of
persistence over 5 years being over 30 times higher (9.5% vs 0.26%) in Cavalerie et al. (2015)
compared to Metras et al. (2017).
Sources of the uncertainty related to vector role in the maintenance of the RVFV in Mayotte and
Reunion were lack of data and possible overestimation of current evidences related to vertical
transmission.
Key Points:
• In summary, both studies suggest that the probability of RVFV persisting in Mayotte for 5 or
more years is < 10% but could be much lower if vertical transmission does not occur.
• Different sources of uncertainty may affect the models developed by Cavalerie et al. (2015) and
Metras et al. (2017). According to the sensitivity analyses performed on both models,
predictions are most sensitive to the biotic and abiotic factors influencing the transmission rate.
In particular, those parameters influencing vector abundance and competence are the most
difficult to estimate from field data compared with laboratory trials. On the other hand, both
models were calibrated using serological data to better fit the model outcomes to the situation
in Mayotte.
• Persistence of RVFV by vertical transmission in Mayotte and Reunion appears to be of minor
relevance compared to other pathways of re-introduction (i.e. animal movement) since in
general it is considered a rare phenomenon with low prevalence in the mosquito population.
However, there is a high uncertainty since there is limited information about the vertical
transmission of some of the major species of vector species of RVFV in Mayotte and Reunion, as
well as the lack of evidences in other RVF endemic countries.
3.3. Assessment of the risk of RVF spread from Mayotte to other areas
including other French departments in the Indian Ocean or to
continental France (TOR 2.1)
In this section, the risk of spread of RVF from Mayotte to other countries is assessed. The target
countries and possible pathways are described and selected, and only for those ones the assessment
of risk of spread is carried out.
3.3.1. Target countries of RVF spread from Mayotte
Among the target countries for possible RVF spread from Mayotte, Metropolitan France and
Reunion are considered, the latter as the only French department in the area, which was never
affected by RVF. Both France and Reunion are also connected by direct flights with Mayotte.
Other countries neighbouring Mayotte, i.e. Tanzania, Kenya, Mozambique, Comoros, Madagascar
and Mauritius, are not French departments; moreover, they are all affected by RVF and are considered
RVF endemic (apart from Mauritius). These countries have to be considered as sources of infection for
Mayotte rather than target countries for spread from Mayotte, and thus, an assessment of the latter
aspect is not relevant. The two introductions (2007/2008 and 2018/2019) of RVFV to Mayotte
originated from mainland East Africa (in Tanzania of animals coming from the surrounding countries)
through Comoros islands and then to Mayotte. In Madagascar, RVFV was introduced in 2008–2009
through ruminant trade, and subsequent movement of cattle between trade hubs caused its long-
distance spread within the country, from Comoros islands. Informal surveys conducted in 2009 and
2010 in the main Comoros harbours and in the northwest of Madagascar (Mahajanga and Antsiranana)
revealed the frequent presence of cattle and small ruminants on board freighters and botry (dhows)
travelling from the Comoros Islands to Madagascar and from port to port (Lancelot et al., 2017).
Moreover, there is no direct flight or sea connection from Mayotte to Mauritius.
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3.3.2. Possible pathways of RVF spread from Mayotte
The possible pathway of spread of RVF from Mayotte to other areas including other French
departments in the Indian Ocean or in continental France are: i) live animals illegally or legally
transported, ii) vectors actively or passively transported through wind currents, flights, boats or ship
and iii) non-processed animal products like raw milk and meat legally or illegally transported iv) human
travellers.
3.3.2.1. Live Animals and Animal Products
According to the information provided by the French Veterinary Authorities, there is no commercial
trade of animals or animal products from Mayotte to other French departments or to European
countries. Mayotte is an importer country of live ruminants, so the trade driver is to import live animals
to Mayotte, this may lead also to illegal movement towards Mayotte and not from Mayotte.
Furthermore, the high price of cattle in Mayotte is a disincentive for exports (see Section 3.1.5).
Therefore, this pathway of spread of RVF from Mayotte through live animals is not plausible and
therefore excluded from the assessment.
Consumption of fresh animal products such as raw milk or raw fresh meat can be a way to transmit
RVFV to humans (LaBeaud et al., 2011). Nevertheless, since RVFV is highly sensitive to low pH and is
thus quickly inactivated in matured meat or dairy products, and no fresh meat or raw milk is exported
from Mayotte (in Mayotte, milk is consumed raw but fermented so at lower pH), this pathway of
possible spread of RVFV from Mayotte is excluded as well from the assessment (EFSA AHAW Panel,
2020).
3.3.2.2. Vectors Pathway
Vectors moved by wind currents
As described in EFSA AHAW Panel (2020), the range of windborne transfer was from 97 km for Ae.
vigilax to 850 km for Cx. pipiens pipiens. For other potential RVFV vectors such as An. pharoensis,
Cx. tritaeniorhynchus and Ae. vexans, there are reports of windborne transportation over 280, 500 and
Figure 15: Geographical position of Mayotte and distance from the main neighbouring countries
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740 km, respectively. The assessment of the risk of spread of RVF from Mayotte to neighbouring
countries such as Tanzania, Kenya, Mozambique, Comoros, Reunion, Madagascar and Mauritius was
carried out by HYSPLIT model; results are presented in Section 3.3.5.
Vectors moved through flights
As described in EFSA AHAW Panel, 2020, mosquitoes can be detected in air cabins and gangways
(EFSA AHAW Panel, 2020). There is a probability that RVFV vectors (i.e.: Culex species) may also be
introduced by plane and therefore to transmit the virus in the surroundings of airports. This also
depends not only on the number of flights connecting RVFV-infected countries to target countries but
also on the epidemiological status of the originating country, the closeness of infected areas to the
airport, etc. In the table below Table 10, the number of outbound direct flights from Mayotte in 2019
is reported. Further details about flights from Mayotte are reported in Appendix D.
According to the assessment of RVFV vectors introduction to EU conducted by Vectornet (Van
Bortel et al., 2020), the probability of importation of infected vectors through airplanes was driven by
the number of direct flights from all at-risk African countries to the respective EU Member State. Only
for the Netherlands, France and Germany, with several thousands of flights per year from some RVF-
affected countries, the value assigned in the MINTRISK model for the average numbers of vectors
moved along the pathway per year was the second lowest category, 100–1,000 vectors per year; for
all the other countries the values assigned corresponded to the lowest category, i.e. < 100 vectors
(‘minimal’), which would be the case also for all the countries listed in Table 9. This would also be the
case for the spread to France and Reunion.
Vectors moved by sea transport
As described in EFSA, 2020, introduction and worldwide expansion of invasive Aedine species such
as Ae. albopictus has been related to ports with high traffic volumes that increase the risk of invasion
from areas that share similar eco-climate conditions.
From Mayotte, there are very limited numbers of ship movement, or on a very small scale, both for
transport of passengers (up to 10 boats per week to Comoros and individual people with private boats
travelling to Madagascar, Comoros or Mozambique) and for container ship (Table 11). In fact, Mayotte
is a small island with very limited export activity (see Section 3.1.5).
Table 10: Number of flights per destination country departing from Mayotte Dzaoudzi –
Pamandzi airport (DZA) in 2019 (the data for the Seychelles are not
included). The flights to France include technical stopovers (passengers stay
on the plane in Kenya)
Destination country No. of flights arriving from Mayotte airport (DZA) in 2019
France 228
Comoros 777
Kenya 149
Madagascar 612
Reunion 453
Saudi Arabia 1
Tanzania 29
Total flights 2,249
Table 11: Containers transported from Mayotte to MSs
2015 2016 2017 2018 2019
Total Empty Total Empty Total Empty Total Empty Total Empty
Belgium 13 4 8 0 19 0
Spain 32 0 17 0 16 0 31 0 19 0
France 131 30 183 2 412 0 810 98 289 241
Data source: Database of Eurostat: Transport/Maritime Transport/Volume of containers transported to/from main ports. Twenty-
foot equivalent unit (TEU).
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This amount is very limited compared to the number of containers moved from other RVF-affected
countries to MS, 20–100 thousand containers moved yearly (EFSA AHAW Panel, 2020), and for which
the risk of introduction of RVFV in EU was already found to be low. Given the very low number of
containers moved from Mayotte per year, this pathway of spread of vectors is excluded from the
assessment.
3.3.2.3. Human Pathway
The great majority of cases of infection with RVFV in humans is asymptomatic. For the small
proportion with clinical signs, the majority presents with a self-resolving influenza-like syndrome.
Although sick people can develop significant levels of viraemia for a few days (EFSA, 2005; Maurice
et al., 2018), humans are considered dead-end hosts in the epidemiological cycle of RVF and human–
human transmission of the virus has never been described (EFSA AHAW Panel, 2020). Therefore, this
pathway of spread is not further considered.
3.3.3. Selection of relevant pathways of RVF spread from Mayotte and target
countries
Considering the information presented in the section above, the pathways of spread from Mayotte
coupled with the target countries to be further considered are:
• movement of infected vectors by passive movements when shipped by flight to metropolitan
France and to Reunion (French Department), to be assessed by MINTRISK model;
• movement of infected vectors by wind currents to countries neighbouring Mayotte.
3.3.4. Risk of spread of RVF from Mayotte to metropolitan France and Reunion
by vectors transported by flights
The assessment of the risk of spread of RVF from Mayotte to France and to Reunion via vectors
moved by flights is carried out by MINTRISK model and it is structured in four components, i.e.
occurrence of the disease in Mayotte, rate of entry, level of transmission and probability of
establishment. Then, the model computes the overall risk of introduction. As in EFSA AHAW Panel, 2020
RVF 1ST Opinion, for each component, a set of questions need to be answered with a value chosen from
a scale given by the model and a related level of uncertainty (low, moderate, high). The values for each
MINTRISK question and the reasoning to assign the different values are given in Table 12.
Table 12: Steps, question and values assigned with related reasoning for MINTRISK
model applied to risk of introduction of RVFV from Mayotte to France and
Reunion by movement of vectors shipped by flights
Step Question Value Reasoning Uncertainty level
RVF
occurrence in
Mayotte
Relative size of the
infected area to the total
area addressed
> 0.3, very
large
Outbreaks all over the island,
see Figure 5
Low
How likely is it that the
disease will not be
notified to OIE
Very unlikely,
< 0.2
See EFSA AHAW Panel (2020) Low
What is the duration of
undetected spread
Short (0.1–
0.3 year)
This was observed in 2018 in
Mayotte, the disease entered in
summer and was detected by
the end of 2018
Moderate
What is the frequency
with which the epidemic
occurs in the addressed
area
Moderate,
0.3–1 per
year
One epidemic per year in 2018
and 2019
Low
How high is the
prevalence of the
infection in vectors in the
region in the end of high-
risk period
High, > 0.1 In 2018 and 2019, there was
an active epidemic, see EFSA
AHAW Panel, (2020)
Moderate
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The results of the assessment by MINTRISK are reported in Table 13.
Step Question Value Reasoning Uncertainty level
Rate of Entry Average numbers vectors
moved along the pathway
per year
Minimal,
< 100, both
for France
and Reunion
Number of flights per year from
Mayotte to France and Reunion
is very limited (< 500 per year,
see above) compared to yearly
number of flights to France
from all African affected
countries (7–9,000 flights).
Mosquito survival is close to 1,
see EFSA AHAW Panel (2020)
Low
Probability of passing
through the preventive/
control measures before/
at transport
Moderate,
0.01–0.1
See EFSA AHAW Panel (2020) High
Probability that a viable
VBD-agent is still present
upon arrival in the area at
risk
Very high,
> 0.8
RVFV is viable in a surviving
vector and the survival of
mosquitos depends on the
length of trip, few hours for
flight to France, less to
Reunion, survival is close to 1
Low
Transmission Distribution of the vector
in the area at risk
Present RVF vectors are present both in
France and in Reunion
Low
Estimated value of the
basic reproduction ratio
2.3–6.8
(moderate to
high)
See EFSA AHAW Panel (2020) Moderate
Fraction of the host
population is susceptible
Very high,
> 0.8
France and Reunion are RVF
free (EFSA, 2020; Balenghien
et al., 2013)
Low
Establishment Probability of infecting a
first local (indigenous)
host, given the pathway
of entry and the expected
region and time of entry?
[1st transmission step]
Very high for
Reunion
moderate for
France
This is calculated as the
geometric mean of temperature
(number of days above 9.6°C,
EFSA AHAW Panel, 2020, which
is 1 for Reunion (Figure 1) and
0.667 for France, EFSA AHAW
Panel, 2020) and host density,
which is moderate for France
(EFSA AHAW Panel, 2020) and
very high for Reunion (170
ruminant/sq.km of agricultural
land). The categories for
MINTRISK have been assigned
according to 20th, 40th, 60th,
80th percentiles of the
distribution of the geometric
means
Low
Probability of infecting a
first local vector (given
first infection of an
indigenous host)? [2nd
transmission step]
Very high for
Reunion
Moderate for
France
This is calculated as the
geometric mean of temperature
(see above) and proportion of
the country with vector
presence, moderate for France
(EFSA AHAW Panel, 2020) and
very high for Reunion (close to
1, see Figure 15). The
categories for MINTRISK have
been assigned according to
20th, 40th, 60th, 80th
percentiles of the distribution of
the geometric means
Low
Rift Valley Fever in Mayotte
www.efsa.europa.eu/efsajournal 45 EFSA Journal 2020;18(4):6093
Key messages:
• The overall risk of RVFV introduction from Mayotte to metropolitan France is 3.55E-06 (1.78E-
08; 0.000708) per year (very low) with 95% certainty, corresponding to one epidemic every
1400 years in the worst-case scenario. Likewise, the overall rate of RVFV introduction from
Mayotte to la Reunion island is 0.001122 (4.47E-06; 0.158489) per year (from very low to low)
with 95% certainty, corresponding to one epidemic every 6.3 years at the maximum (upper
bound as worst case scenario).
• The very low values of introduction risk originate from very low rates of importation of infected
vectors from Mayotte because of very small number of direct flights connecting Mayotte to
metropolitan France and la Reunion island. Therefore, the number of direct flights as a proxy
represents a bottleneck to the introduction of RVFV from Mayotte into target areas.
• The risk of RVFV introduction from Mayotte to la Reunion is greater than that from Mayotte to
metropolitan France mainly because the probability of establishment in la Reunion (median:
0.282; 95%CI: 0.112–0.708) is much higher than that in metropolitan France (median: 0.0001;
95%CI: 2.51E-05–0.000398). Although quite similar in terms of entry rate (median: 3.55E-05;
95%CI: 1.59E-07–0.0071) and level of transmission (median: 1.78; 95%CI: 0.47–6.68), la
Reunion exhibits more favourable conditions (higher host density and weather conditions) for
RVF establishment than metropolitan France.
3.3.5. Dispersal of RVFV-infected mosquitoes between Mayotte and
neighbouring countries by wind
Analysis of wind trajectories using the HYSPLIT model suggests that mosquitoes could potentially
have been transported on wind to Mayotte from the Comoros Islands or Madagascar in both January
2008 and December 2018 (Figure 16). Consequently, either country could be a possible source for a
wind-borne incursion of RVFV-infected mosquitoes to Mayotte in 2008 or 2018. Because no trajectories
originate from Mozambique, Tanzania or Kenya, it is unlikely that these countries were direct sources
for a wind-borne incursion to Mayotte in either year.
Table 13: MINTRISK results of rate of entry, transmission, probability of establishment and risk of
introduction of RVFV in Reunion and France
Steps
Reunion France
Values (median
and CI)
Qualitative
assessment
Values
Qualitative
assessment
Rate of entry (number of
entry/year)
3.55E-05
(1.58E-07, 0.007)
Very low 3.55E-05
(1.58E-07, 0.01)
Very low
Level of transmission (R0) 1.78 (0.47; 6.68) Moderate 1.78 (0.47; 6.68) Moderate
Probability of establishment 0.28 (0.11; 0.70) Very high 0.0001
(2.51E-05; 0.0004)
Low/moderate
Overall risk of introduction
(number of epidemics per
year)
0.001
(4.47E-06; 0.16)
Very low/low 3.55E-06
(1.78E-08; 0.0007)
Very low
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During the most recent epidemic of RVF on the island in 2019, analysis of wind trajectories using
the HYSPLIT model indicates that mosquitoes from Mayotte dispersing on the wind could have reached
the Comoros Islands, Madagascar, Mozambique and, possibly, Tanzania after 48 h (Figure 17).
However, these four countries report endemic disease (EFSA AHAW Panel, 2020), and an incursion of
RVFV-infected mosquitoes would have negligible impact. Trajectories from Mayotte did not reach any
other countries and so no other countries are likely (since none of trajectories reached targets) to have
been at risk of RVFV being introduced by the long-distance dispersal of mosquitoes from Mayotte
between January and April 2019. The trajectories reaching Mauritius (approximately 20.5°S, 57.5°E) in
February 2019 (Figure 17) should be interpreted with caution. More detailed examination of the
trajectories indicated that these were > 10,000 m above ground level, so no mosquitoes would be
expected to survive.
The colour scale indicates the proportion (%) of wind trajectories from the Comoros Islands or Madagascar
passing through each 1° by 1° grid square which reach Mayotte (indicated by the star) within 48 h.
Figure 16: HYSPLIT backwards trajectories of 48 h duration for wind-borne dispersal of mosquitoes
to Mayotte in January 2008 (a) or December 2018 (b)
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Analysis of wind trajectories from Mayotte using HYPSLIT indicates that RVF could be introduced
into neighbouring countries by wind-borne dispersal of mosquitoes from Mayotte. The reverse (i.e. RVF
introduction from Comoros and Madagascar to Mayotte) is possible as well. This finding suggests the
potential for a pendulum or ping-pong movement of RVF between Mayotte and the neighbouring
countries.
4. Conclusions
• The tropical climate in Mayotte provides favourable conditions for the presence of mosquitoes
all year round; the temperature remains high (25.4°C average, 15°C min, 31°C max) and
rainfall is present throughout the year (high peaks from late November to March).
• Regular illegal introductions of animals into Mayotte, represent a continuous risk of (re)
introduction of RVF and other diseases.
• The size of the herds is small, with 4.8 and 5.8 ruminants per farm on average for bovines and
small ruminants, respectively. The farming system in both bovines and small ruminants is
traditional, mainly based on tethered grazing, with low levels of biosecurity.
• Animal registration and identification systems are not fully implemented, with consequent
uncertainties on the real demographic data of farmed ruminants in Mayotte.
• The animal population of Mayotte has been continuously exposed to RVFV at least since 2004
or even earlier, given that RVVF-specific IgG antibodies were detected in sera samples
collected in 2004. RVF-specific IgM antibodies were not identified before 2007, when RVFV-
infected ruminants were illegally introduced from the Union of the Comoros.
• After a decade (2007–2018) of decrease in the RVF sero-prevalence, RVFV was re-introduced
in 2018, most probably through illegal imports of live animals (mainly goats) from the Union of
The colour scale indicates the proportion (%) of wind trajectories from Mayotte (indicated by the star) passing
through each square of a 1° by 1° grid.
Figure 17: HYPSLIT forward trajectories of 48 h duration for wind-borne dispersal of mosquitoes
from Mayotte in (a) January, (b) February, (c) March or (d) April 2019
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the Comoros during the preparation for the celebration of Eid al Adha. Up to the end of
October 2019, 126 outbreaks of RVF in ruminants, distributed all over the island, were
reported in Mayotte.
ToR 2.1a. Probability of RVF persistence in Mayotte
• The probability of persistence of RVF in Mayotte in animal hosts is considered low, since
transplacental transmission in ruminants is considered rare, there is no known carrier state in
mammals and there are no wild ruminants in Mayotte, in which RVFV could persist;
• Vertical transmission via vectors in Mayotte appears to contribute less to persistence of RVF
compared to the re-introduction via pathways such as animal movement from RFVF-infected
areas. Firstly, persistence is considered a rare phenomenon of low prevalence in the mosquito
population. Secondly, vertical transmission of RVFV has not been detected in any of potential
vector species of RVFV present in Mayotte and Reunion. However, there is a high uncertainty
regarding the existence of vertical transmission, given the limited information available in other
RVF endemic countries.
• Two published mathematical models assessed the probability of RVF persistence in Mayotte.
The first suggests that, assuming vertical transmission in vectors occurs, the probability of
RVFV persisting in Mayotte was 9.5% and 2.1% for a persistence of 5 and 9 years,
respectively. A second model did not consider vertical transmission in vectors and the study
based on this indicates that, once importation of RVFV-infected animals stopped, the virus was
predicted to persist in only 0.26% of simulations. Indeed, without vertical transmission in the
vector or the continuous re-introduction of the virus through infected animals or vectors,
persistence is unlikely.
• The progressive decrease of serological positivity after RVF introduction in 2007 indicates that
probably the virus circulation did not persist after that year, until the re-introduction in 2018.
• The low chance of RVF persistence in Mayotte can be due to the small number of susceptible
hosts in the island and the slow turnover of the ruminant population.
• Moreover, a recent study on genetic sequencing has shown that RVFV circulating in the 2018–
2019 epidemics is different from the one in 2007, thus this supports the fact that the current
epidemics are due to re-introduction rather than RVF persisting in the island.
ToR 2.1b. Risk of spread from Mayotte to other countries including other French
departments in the Indian Ocean or to continental France
• In relation to the risk of RVF spread from Mayotte to other countries including other French
departments in the Indian Ocean or to continental France, various possible pathways have
been analysed:
○ According to the information provided by the French Veterinary Authorities, there is no
commercial trade of animals or animal products from Mayotte to other French departments
or to other European countries. Moreover, the sale of raw milk is banned. Therefore, the
possible spread of RVF form Mayotte through live animals and animal products is deemed
non-existent.
○ Concerning the possibility of spreading the infection through infected vectors carried by
airplanes, there are few direct flights connections from Mayotte to continental France and
other French departments in Indian Ocean (Reunion). The overall risk of introduction of
RVF through this pathway was assessed by MINTRISK model as ‘Very low’ for continental
France (median of 4 9 106 epidemic per year (95%CI: 2E-08; 0.0007), corresponding to
one resulting epidemic every 1,400 years, based on the upper bound of the confidence
interval as worst-case scenario) and ‘Very low to low’ for Reunion (median of 0.001
epidemics per year (95%CI: 4.47E-06; 0.16), corresponding to one resulting epidemic
every 6.3 years, based on the upper confidence level as worst-case scenario).
○ In relation to the possibility of spread of RVF through infected vectors carried by sea
cargo, the limited number of containers annually departing from Mayotte suggests that the
probability of RFV spread from Mayotte through this pathway is very low.
○ Simulations with the HYSPLIT model suggest that mosquitoes dispersing on the wind from
Mayotte between January and April 2019 could have reached the Comoro Islands,
Madagascar, Mozambique and, possibly, Tanzania after 48 h. However, these four countries
report endemic disease, and an incursion of RVFV-infected mosquitoes would not change
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the prevalence noticeably. No other countries were at risk of RVFV being introduced by the
long-distance dispersal of mosquitoes from Mayotte during this same time period. The
same model shows also that the backward spread may also occur, while Comoro Islands
and Madagascar have been possible sources for a wind-borne incursion of RVFV-infected
mosquitoes to Mayotte in 2008 or 2018.
ToR 2.2. Impact of RVF in Mayotte
• The animal population in Mayotte has been exposed to RVF virus at least since 2004 or even
earlier, since RVF-specific IgG antibodies were detected in serum samples in 2004. RVF-specific
IgM antibodies were not identified before 2007, when RVFV-infected ruminants were illegally
introduced from the Union of the Comoros.
• Since 2007, after a decade during which the sero-prevalence of RVF was decreasing, in 2018
RVFV was re-introduced, most probably through illegal imports of live ruminants (mainly goats)
from the Union of the Comoros during the preparation for the celebration of Eid al Adha. Up to
the end of October 2019, 125 outbreaks of RVF, distributed all over the island, were reported
in Mayotte domestic ruminants.
• In the 2018–2019 epidemic, according to official notifications, RVF caused low mortality
(0.01%). However, in 2019, the number of abortions reported in ruminants was fivefold
greater than the years before. The majority of the aborted foetuses tested had RVFV.
• According to the only available data, originating from one farm affected by the 2018–2019
outbreak, the weekly milk production in weeks 29–41 of 2019 was at lower levels than
expected based on the period 2015–2018. This drop in the milk production from week 29 to
week 41 would be temporally compatible with the reproductive perturbations (abortions, foetal
resorptions) caused by RVFV infection, which occurred in late 2018 and early 2019. In
addition, albeit the dairy farm under study was infected by RVFV, it cannot be concluded with
certainty that the infection was the main cause of the observed milk drop. Milk loss in 2019
compared to previous years 2015–2018 is estimated to be 18%, which would correspond to an
economic loss of around €191,000 in the entire Mayotte.
5. Recommendations
• Considering the risk of spread of RVF from and towards Mayotte, it is recommended to
maintain and even to improve actions preventing introduction of infected vectors from and
towards Mayotte from infected areas and to other uninfected areas, such as Metropolitan
France and Reunion. Particular attention should be given to air traffic connections from
Mayotte to exposed areas (Reunion, Comoros, Madagascar, Kenya/France, Tanzania/France)
and improve the surveillance in neighbouring countries.
• Considering the likely repeated introduction of RVFV in Mayotte from Comoros through illegal
movement of live animals, it is recommended to strengthen and support surveillance and
border control measures in Mayotte to reduce this event.
• Considering the risk of Mayotte to be exposed to introduction of RVFV, it is of paramount
importance to strengthen and improve the surveillance in order to follow the evolution of RVF
occurrence in both Mayotte and neighbouring countries.
• Although the data available do not allow a solid estimation of the impact of RVF on animal
health and production in Mayotte, it is recommended to implement a more structured system
for the recording of disease occurrence and possible production losses, including abortions and
milk production in order to understand the impact of RVF in Mayotte. A better implementation
of the animal identification and registration system and tracing of movements would be of
benefit for such objective.
• In general, the role of vertical transmission in RVFV vectors for the persistence of the disease
from one year to another or even between inter-epizootic episodes is still poorly understood.
Long-term studies about the prevalence of viable RVFV in immature stages of mosquitoes are
recommended.
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RVF Rift Valley fever
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Appendix A – Population data of ruminants in each commune in Mayotte
according to the last agricultural census of 2010
Commune/Municipality in Mayotte Cattle Sheep and Goats
Herds N (%) Animals N (%) Herds N (%) Animals N (%)
Acoua 90 (2.51) 236 (1.38) 92 (4.20) 367 (2.91)
Bandraboua 234 (6.53) 880 (5.13) 93 (4.25) 836 (6.62)
Bandrele 355 (9.91) 1,432 (8.35) 207 (9.46) 1,100 (8.72)
Boueni 97 (2.71) 289 (1.68) 154 (7.04) 777 (6.16)
Chiconi 291 (8.13) 1,363 (7.95) 62 (2.83) 314 (2.49)
Chirongui 248 (6.93) 1,013 (5.91) 94 (4.29) 389 (3.08)
Dembeni 314 (8.77) 1,690 (9.85) 212 (9.68) 1,294 (10.25)
Dzaoudzi 98 (2.74) 474 (2.76) 76 (3.47) 545 (4.32)
Kani-Keli 213 (5.95) 1,114 (6.49) 116 (5.30) 676 (5.36)
Koungou 188 (5.25) 641 (3.74) 253 (11.56) 1,235 (9.79)
Mamoudzou 596 (16.64) 3,106 (18.11) 380 (17.36) 2,196 (17.40)
Mtsamboro 77 (2.15) 325 (1.89) 114 (5.21) 649 (5.14)
M’Tsangamouji 124 (3.46) 649 (3.78) 45 (2.06) 264 (2.09)
Ouangani 222 (6.20) 875 (5.10) 98 (4.48) 458 (3.63)
Pamandzi 22 (0.61) 184 (1.07) 13 (0.59) 117 (0.93)
Sada 180 (5.03) 1,158 (6.75) 69 (3.15) 525 (4.16)
Tsingoni 232 (6.48%) 1,725 (10.06) 111 (5.07) 877 (6.95)
Total 3,581 17,154 2,189 12,619
Source: DAAF Mayotte.
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Appendix B – Publications with sero-surveillance studies of RVF in Mayotte
Sampling
period
Animal
species
N
tested
Diagnostic
method
Positive
results
(% on
the
samples)
Seroprevalence
with CI
Method Publication
2004 Cattle 130 In house IgG
ELISA; confirmed
by neutralisation
tests
29
(22.66%)
Retrospective
study in
stored
samples
Cetre-Sossah
et al.
(2012a)
2005 130 In house IgG
ELISA; confirmed
by neutralisation
tests
4 (3.07%)
2006 130 In house IgG
ELISA; confirmed
by neutralisation
tests
16
(12.31%)
2007 126 In house IgG
ELISA; confirmed
by neutralisation
tests
39
(30.95%)
September
2007 to
March
2008
Humans 220 In-house IgM-
capture enzyme
immunoassays
ELISA
3 Retrospective
study in
patients
Sissoko et al.
(2009a) and
Cetre-Sossah
et al.
(2012b)RT-PCR by
Drosten et all
2002
7
Virus isolation 2
November
2007 to
April 2008
Goats
(Illegally
introduced)
29 In-house
competitive IgG
ELISA
4
(13.79%)
Cetre-Sossah
et al.
(2012a)
In-house IgM-
capture ELISA
2 (6.89%)
Cattle close
to goats
79 In-house
competitive IgG
ELISA
29 (37%)
In-house IgM-
capture ELISA
3 (4%).
Jun 2007
to May
2008
Cattle 301 In-house
competitive IgG
ELISA
32 (10.6%
(95% CI
7%–14%)
Cetre-Sossah
et al.
(2012a)
Aug. 2008
to Aug.
2009
Goats 70 Seroconversion
(IgG)
1 (1.43%) Cetre-Sossah
et al.
(2012a)IgM Identification
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Sampling
period
Animal
species
N
tested
Diagnostic
method
Positive
results
(% on
the
samples)
Seroprevalence
with CI
Method Publication
March
2010 to
August
2011
Cattle 131 ELISA kits for IgG
RVFV antibodies
Prospective,
monthly
sampling,
seronegative
sentinels,
randomly
selected
farms
Lernout et al.
(2013)
Small
ruminants
67
March–
April 2011
Humans 1,413 IgG in-house
indirect ELISA test
(Pasteur, Paris)
58 (4.1%)
October
2004 to
April 2013
Ruminants 2,342 Competitive Elisa
Kit
This study incudes also data
from other published studies
Cavalerie
et al. (2015)
October
2004 to
June 2015
Cattle 5,720 IgG This study includes the
samples already used in some
of the studies mentioned
above, and the results per
epidemiological year are
included in Table 3
Metras et al.
(2015)Goats
Cattle 1,513 IgM
Goats
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Appendix C – Cumulated number of RVF affected herds and human cases
and number of new confirmed herds and human cases in 2019 in Mayotte
Date of press
release
Cumulated number
of herds
Cumulated number of
human cases
New herds
confirmed
New human cases
confirmed
17/1/2019 0 5 0 5
6/2/2019 23 31 23 26
22/2/2019 33 63 10 32
1/3/2019 39 82 6 19
8/3/2019 52 88 13 6
15/3/2019 60 101 8 13
22/3/2019 75 107 15 6
29/3/2019 84 114 9 7
4/4/2019 86 116 2 2
11/4/2019 92 117 6 1
18/4/2019 104 122 12 5
26/4/2019 109 126 5 4
10/5/2019 119 130 10 4
24/5/2019 121 134 2 4
3/6/2019 123 137 2 3
14/6/2019 124 139 1 2
21/6/2019 124 139 0 0
28/6/2019 124 139 0 0
05/7/2019 124 141 0 2
12/7/2019 126 142 2 1
2/8/2019 126 142 0 0
16/8/2019 126 143 0 1
30/8/2019 126 143 0 0
Total 126 143
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Appendix D – Number of flights per destination country departing from
Mayotte Dzaoudzi – Pamandzi airport (DZA) per month in 2019
Destination
Country
Destination City
Number of flights arriving from Mayotte airport (DZA) in
2019
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
Comoros/
Madagascar
MORONI/
ANTANANARIVE
4 4 5 1 0 0 8 0 0 0 0 0 22
Comoros ANJOUAN 53 36 34 9 20 22 27 27 9 14 2 22 275
Comoros ANJOUAN/MOHELI 0 0 0 0 0 0 0 0 1 0 0 0 1
Comoros ANJOUAN/MORONI 0 0 21 21 27 24 26 29 25 26 26 27 252
Comoros MOHELI 8 5 3 5 9 8 9 9 5 8 9 9 87
Comoros MORONI 17 11 10 8 9 10 23 26 12 9 5 17 157
Comoros MORONI/ANJOUAN 0 0 1 4 0 0 0 0 0 0 0 0 5
France PARIS-CDG 0 0 0 4 15 23 13 14 2 1 2 3 77
Greece/France ATHENS/PARIS-CDG 0 0 0 0 0 0 3 0 0 0 0 0 3
Kenya NAIROBI 13 15 13 13 14 9 13 9 14 11 13 12 149
Kenya/France MOMBASSA/PARIS-CDG 0 0 0 0 0 2 0 0 0 0 0 0 2
Kenya/France NAIROBI/PARIS-CDG 14 10 11 12 0 1 0 0 5 17 10 18 98
Madagascar ANTANANARIVE 10 8 8 7 9 9 1 9 9 9 8 9 96
Madagascar DIEGO-SUAREZ 7 5 8 7 5 5 9 13 3 11 3 10 86
Madagascar DIEGO-SUAREZ/NOSY BE 5 4 4 3 2 3 7 5 7 9 6 6 61
Madagascar MAJUNGA 22 17 19 17 18 17 26 24 14 17 13 24 228
Madagascar NOSY BE 6 4 5 7 8 6 10 9 3 11 3 10 82
Madagascar NOSY BE/DIEGO-SUAREZ 5 4 3 7 4 2 1 1 0 3 3 4 37
Mayotte DZAOUDZI 0 0 0 0 0 0 1 0 0 0 0 0 1
Reunion REUNION 40 29 36 31 34 39 52 52 34 32 30 44 453
Seychelles MAHE 0 0 0 0 0 0 0 3 1 0 0 0 4
Tanzania DAR-ES-SALAAM 3 2 3 2 2 2 4 3 2 3 0 3 29
Tanzania/France DAR ES SALAAM/PARIS-
CDG
0 0 0 0 0 0 14 17 17 0 0 0 48
Tanzania/Saudi
Arabia
DAR ES SALAAM/JED 0 0 0 0 0 0 1 0 0 0 0 0 1
Total 207 154 184 158 176 182 248 250 163 181 133 218 2,254
Some of the flights have stopovers e.g. there are 98 flights to Paris CDG airport that have a stopover in Nairobi.
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Appendix E – Milk production in 2015–2018 and in 2019 per each week in the study farm
The detailed milk production in 2015–2018 and in 2019 per each week with related number of dairy cows present in each week in the study farm is
shown in Figure E.1.
In Figure E.2, the deviation of milk production in 2019 from expected production in the reference period (2015–2018) is shown per week expressed as
milk production in 2019 minus the lowest bound of reference period 2015–2018 (low CI) divided by low CI. The cumulated milk loss in litres is also shown.
Figure E.1: Weekly milk production (total milk yield, right Y-axis) during period 2015–2018 and in 2019 in relation to number of dairy cows (left Y-axis)
present in the study farm
www.efsa.europa.eu/efsajournal 60 EFSA Journal 2020;18(4):6093
Rift Valley Fever in Mayotte
Left y-axis corresponds to the production anomaly (vertical bars, expressed as milk production in 2019 minus the lowest bound of reference period 2015–2018 (low CI) divided by
low CI and the right y-axis to the total loss of milk (dashed line) in 1,000 L.
Figure E.2: Deviation of milk production in 2019 from expected production in the reference period (2015–2018)
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